{"DataElement":{"publicId":"4824544","version":"1","preferredName":"Sarcoma World Health Organization Classification Category","preferredDefinition":"Text term that represents the World Health Organization (WHO) classification for the patient's Sarcoma diagnosis, usually an aggressive malignant neoplasm of soft tissue or bone.","longName":"SAR_WHO_CLAS_CAT","context":"DCI","contextVersion":"1","DataElementConcept":{"publicId":"4824543","version":"1","preferredName":"Sarcoma World Health Organization Classification","preferredDefinition":"A usually aggressive malignant neoplasm of soft tissue or bone.  It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma._A United Nations agency established to coordinate international health activities and to help governments improve health services._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"3113260v1.0:2774744v1.0","context":"DCI","contextVersion":"1","ObjectClass":{"publicId":"3113260","version":"1","preferredName":"Sarcoma","preferredDefinition":"A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004","longName":"C9118","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899A4990-3052-0CBB-E040-BB89AD434572","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-22","modifiedBy":"ONEDATA","dateModified":"2010-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2774744","version":"1","preferredName":"World Health Organization Classification","preferredDefinition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C75419:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization","conceptCode":"C75419","definition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5483FFD2-8987-0AC0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-15","modifiedBy":"ONEDATA","dateModified":"2008-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"WHO Classification of Tumours of Soft Tissue and Bone. 2013.  Fourth Edition","workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-5073-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Sarcoma_DCI_05.12.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4824032","version":"1","preferredName":"Sarcoma World Health Organization Classification Category","preferredDefinition":"A usually aggressive malignant neoplasm of soft tissue or bone.  It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma._A United Nations agency established to coordinate international health activities and to help governments improve health services._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._A grouping of items based on some commonality or by user defined characteristics.","longName":"SARC_WHO_CLAS_CAT","context":"DCI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Acral fibromyxoma","valueDescription":"Acral Fibromyxoma","ValueMeaning":{"publicId":"4826479","version":"1","preferredName":"Acral Fibromyxoma","longName":"4826479","preferredDefinition":"A benign fibroblastic neoplasm that arises from acral sites, usually the periungual area of the digits.  It is characterized by the proliferation of spindled and stellate-shaped fibroblasts in the dermis in a myxoid or collagenous stroma.  Nuclear atypia is usually minimal.  It usually presents as a solitary and slow-growing dome-shaped mass on a digit. The recurrence rate is low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acral Fibromyxoma","conceptCode":"C121713","definition":"A benign fibroblastic neoplasm that arises from acral sites, usually the periungual area of the digits.  It is characterized by the proliferation of spindled and stellate-shaped fibroblasts in the dermis in a myxoid or collagenous stroma.  Nuclear atypia is usually minimal.  It usually presents as a solitary and slow-growing dome-shaped mass on a digit. The recurrence rate is low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9A9D-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9AB6-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Benign Triton tumor","valueDescription":"Benign Triton Tumor","ValueMeaning":{"publicId":"4826480","version":"1","preferredName":"Benign Triton Tumor","longName":"4826480","preferredDefinition":"A very rare intraneural mass in a large nerve characterized by the interposition of mature skeletal muscle fibers and nerve fibers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Triton Tumor","conceptCode":"C121687","definition":"A very rare intraneural mass in a large nerve characterized by the interposition of mature skeletal muscle fibers and nerve fibers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9AC2-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9ADB-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Bizarre parosteal osteochondromatous proliferation","valueDescription":"Bizarre Parosteal Osteochondromatous Prolifeartion","ValueMeaning":{"publicId":"4826481","version":"1","preferredName":"Bizarre Parosteal Osteochondromatous Prolifeartion","longName":"4826481","preferredDefinition":"A benign lesion that usually affects the proximal small bones of the hands or feet.  Grossly it consists of a cartilage cap and a bony stalk.  Microscopically it is characterized by the presence of spindle cells, cartilage, and bone, usually in a disorganized pattern compared to subungual exostosis.  Enlarged (bizarre) chondrocytes are present in the cartilage.  Swelling with or without pain is present.  Recurrences following resection have been reported in approximately half of cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bizarre Parosteal Osteochondromatous Proliferation","conceptCode":"C121845","definition":"A benign lesion that usually affects the proximal small bones of the hands or feet.  Grossly it consists of a cartilage cap and a bony stalk.  Microscopically it is characterized by the presence of spindle cells, cartilage, and bone, usually in a disorganized pattern compared to subungual exostosis.  Enlarged (bizarre) chondrocytes are present in the cartilage.  Swelling with or without pain is present.  Recurrences following resection have been reported in approximately half of cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9AE7-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9B00-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Chondrosarcoma Grade II","valueDescription":"Grade II Chondrosarcoma","ValueMeaning":{"publicId":"4826482","version":"1","preferredName":"Grade II Chondrosarcoma","longName":"4826482","preferredDefinition":"An intermediate-grade chondrosarcoma characterized by the presence of increased cellularity and greater degree of nuclear atypia and hyperchromasia compared to grade I chondrosarcoma.  Mitotic figures can be detected.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondrosarcoma, Grade 2","conceptCode":"C121870","definition":"An intermediate-grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma. It is characterized by the presence of increased cellularity and a greater degree of nuclear atypia and hyperchromasia as compared to grade 1 chondrosarcoma. Mitotic activity is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9B0C-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9B25-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Chondrosarcoma Grade III","valueDescription":"Grade III Chondrosarcoma","ValueMeaning":{"publicId":"4826483","version":"1","preferredName":"Grade III Chondrosarcoma","longName":"4826483","preferredDefinition":"A high-grade chondrosarcoma characterized by the presence of higher cellularity and greater degree of nuclear atypia and pleomorphism compared to grade II chondrosarcoma.  Mitotic figures are easily detected.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondrosarcoma, Grade 3","conceptCode":"C121871","definition":"A high-grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma. It is characterized by the presence of increased cellularity and a greater degree of nuclear atypia, hyperchromasia, and mitotic activity as compared to grade 2 chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9B31-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9B4A-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Dermal nerve sheath myxoma","valueDescription":"Dermal Nerve Sheath Myxoma","ValueMeaning":{"publicId":"4826484","version":"1","preferredName":"Dermal Nerve Sheath Myxoma","longName":"4826484","preferredDefinition":"A usually painless, slow growing benign tumor that most often arises from the extremities. It is characterized by the presence of abundant myxoid matrix and small epithelioid neoplastic Schwann cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermal Nerve Sheath Myxoma","conceptCode":"C121680","definition":"A usually painless, slow growing benign tumor that most often arises from the extremities. It is characterized by the presence of abundant myxoid matrix and small epithelioid neoplastic Schwann cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9B56-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9B6F-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Enchondromatosis:  Ollier disease","valueDescription":"Enchondromatosis","ValueMeaning":{"publicId":"3211042","version":"1","preferredName":"Enchondromatosis","longName":"3211042","preferredDefinition":"A rare benign disorder characterized by lack of normal endchondral ossification, and the growth of multiple enchondromas.  It primarily affects the bones of the hand, in children and young adults.  Extent of the disease varies; in some cases, neoplastic involvement may be wide spread causing considerable deformity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enchondromatosis","conceptCode":"C3008","definition":"A rare benign disorder characterized by lack of normal endochondral ossification, and the growth of multiple enchondromas.  It primarily affects the bones of the hand, in children and young adults.  Extent of the disease varies; in some cases, neoplastic involvement may be widespread causing considerable deformity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C598-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9B83-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Hemosiderotic fibrolipomatous tumor","valueDescription":"Hemosiderotic Fibrolipomatous Tumor","ValueMeaning":{"publicId":"4826485","version":"1","preferredName":"Hemosiderotic Fibrolipomatous Tumor","longName":"4826485","preferredDefinition":"A non-encapsulated, slow-growing, locally aggressive subcutaneous tumor characterized by the presence of adipocytes, hemosiderin-laden spindle cells, hemosiderin-laden macrophages, osteoclast-like giant cells, and scattered chronic inflammatory cells. It usually arises from the dorsum of the foot, ankle, dorsum of the hand, thigh, calf, or cheek.  It may recur if it is not completely excised but does not metastasize.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemosiderotic Fibrolipomatous Tumor","conceptCode":"C121752","definition":"A non-encapsulated, slow-growing, locally aggressive subcutaneous tumor characterized by the presence of adipocytes, hemosiderin-laden spindle cells, hemosiderin-laden macrophages, osteoclast-like giant cells, and scattered chronic inflammatory cells. It usually arises from the dorsum of the foot, ankle, dorsum of the hand, thigh, calf, or cheek.  It may recur if it is not completely excised but does not metastasize.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9B8F-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9BA8-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Hybrid nerve sheath tumors","valueDescription":"Hybrid Nerve Sheath Tumor","ValueMeaning":{"publicId":"4826486","version":"1","preferredName":"Hybrid Nerve Sheath Tumor","longName":"4826486","preferredDefinition":"A benign nerve sheath tumor characterized by the combination of histologic features seen in schwannomas, neurofibromas, and perineuriomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hybrid Nerve Sheath Tumor","conceptCode":"C121686","definition":"A benign nerve sheath tumor characterized by the combination of histologic features seen in schwannomas, neurofibromas, and perineuriomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9BB4-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9BCD-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Mixed tumor NOS","valueDescription":"Mixed Tumor, Not Otherwise Specified","ValueMeaning":{"publicId":"4826487","version":"1","preferredName":"Mixed Tumor, Not Otherwise Specified","longName":"4826487","preferredDefinition":"A benign myoepithelioma characterized by the presence of a minor ductal component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Tumor, Not Otherwise Specified","conceptCode":"C121786","definition":"A benign myoepithelioma characterized by the presence of a minor ductal component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9BD9-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9BF2-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Mixed tumor NOS, malignant","valueDescription":"Malignant Mixed Tumor, Not Otherwise Specified","ValueMeaning":{"publicId":"4826488","version":"1","preferredName":"Malignant Mixed Tumor, Not Otherwise Specified","longName":"4826488","preferredDefinition":"A malignant myoepithelioma characterized by the presence of a minor ductal component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Mixed Tumor, Not Otherwise Specified","conceptCode":"C121787","definition":"A malignant myoepithelioma characterized by the presence of a minor ductal component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9BFE-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9C17-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Nasal glial heterotopia","valueDescription":"Nasal Glial Heterotopia","ValueMeaning":{"publicId":"4826489","version":"1","preferredName":"Nasal Glial Heterotopia","longName":"4826489","preferredDefinition":"A collection of heterotopic neuroglial tissue which is isolated from the cranial cavity, usually located in or around the nose.  Complete excision is curative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal Glial Heterotopia","conceptCode":"C121688","definition":"A collection of heterotopic neuroglial tissue which is isolated from the cranial cavity, usually located in or around the nose.  Complete excision is curative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9C23-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9C3C-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Ossifying fibromyxoid tumor","valueDescription":"Ossifying Fibromyxoid Tumor","ValueMeaning":{"publicId":"3123913","version":"1","preferredName":"Ossifying Fibromyxoid Tumor","longName":"3123913","preferredDefinition":"A rare soft tissue neoplasm of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma.  The lesions are associated with the formation of metaplastic bone.  Most patients present with painless subcutaneous masses.  Recurrences have been reported in a minority of patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ossifying Fibromyxoid Tumor","conceptCode":"C6582","definition":"A rare soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma.  The lesions are associated with the formation of metaplastic bone.  Most patients present with painless subcutaneous masses.  Recurrences have been reported in a minority of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4409-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9C46-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Ossifying fibromyxoid tumor, malignant","valueDescription":"Malignant Ossifying Fibromyxoid Tumor","ValueMeaning":{"publicId":"4826490","version":"1","preferredName":"Malignant Ossifying Fibromyxoid Tumor","longName":"4826490","preferredDefinition":"An ossifying fibromyxoid tumor characterized by the presence of high grade nuclear features or increased cellularity and more than two mitotic figures per 50 HPFs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Ossifying Fibromyxoid Tumor","conceptCode":"C121774","definition":"An ossifying fibromyxoid tumor characterized by the presence of high grade nuclear features or increased cellularity and more than two mitotic figures per 50 HPFs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9C52-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9C6B-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Osteochondromyxoma","valueDescription":"Osteochondromyxoma","ValueMeaning":{"publicId":"4826491","version":"1","preferredName":"Osteochondromyxoma","longName":"4826491","preferredDefinition":"A rare benign chondroid and osteoid matrix-producing neoplasm of bone characterized by extensive myxoid changes.  It may be a locally destructive neoplasm and has been reported in patients with Carney complex.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteochondromyxoma","conceptCode":"C121842","definition":"A rare benign chondroid and osteoid matrix-producing neoplasm of bone characterized by extensive myxoid changes.  It may be a locally destructive neoplasm and has been reported in patients with Carney complex.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9C77-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9C8F-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"PEComa NOS, benign","valueDescription":"Benign PEComa","ValueMeaning":{"publicId":"4826492","version":"1","preferredName":"Benign PEComa","longName":"4826492","preferredDefinition":"A tumor with perivascular epithelioid cell differentiation characterized by the absence of pleomorphism and scarcity or absence of mitotic figures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign PEComa","conceptCode":"C121791","definition":"A tumor with perivascular epithelioid cell differentiation characterized by the absence of pleomorphism and scarcity or absence of mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9C9C-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9CB5-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"PEComa NOS, malignant","valueDescription":"Malignant PEComa","ValueMeaning":{"publicId":"4826493","version":"1","preferredName":"Malignant PEComa","longName":"4826493","preferredDefinition":"A usually large and aggressive tumor with perivascular epithelioid cell differentiation characterized by the presence of marked nuclear atypia, pleomorphism, increased mitotic activity, necrosis, and infiltrative margins.  The most common metastatic sites are liver, lungs, lymph nodes, and bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant PEComa","conceptCode":"C121792","definition":"A usually large and aggressive tumor with perivascular epithelioid cell differentiation characterized by the presence of marked nuclear atypia, pleomorphism, increased mitotic activity, necrosis, and infiltrative margins.  The most common metastatic sites are liver, lungs, lymph nodes, and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9CC1-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9CDA-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Phosphaturic mesenchymal tumor, benign","valueDescription":"Benign Phosphaturic Mesenchymal Tumor","ValueMeaning":{"publicId":"4826494","version":"1","preferredName":"Benign Phosphaturic Mesenchymal Tumor","longName":"4826494","preferredDefinition":"A phosphaturic mesenchymal tumor with benign histologic features.  It may recur locally but does not metastasize.  Complete excision is curative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Phosphaturic Mesenchymal Tumor","conceptCode":"C121788","definition":"A phosphaturic mesenchymal tumor with benign histologic features.  It may recur locally but does not metastasize.  Complete excision is curative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9CE6-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9CFF-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Phosphaturic mesenchymal tumor, malignant","valueDescription":"Malignant Phosphaturic Mesenchymal Tumor","ValueMeaning":{"publicId":"4826495","version":"1","preferredName":"Malignant Phosphaturic Mesenchymal Tumor","longName":"4826495","preferredDefinition":"A phosphaturic mesenchymal tumor that has metastasized from its original site of growth to other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Phosphaturic Mesenchymal Tumor","conceptCode":"C121789","definition":"A phosphaturic mesenchymal tumor characterized by the presence of nuclear atypia, high mitotic activity, increased cellularity, marked pleomorphism, and necrosis. It usually develops in lesions that have recurred locally and metastasizes to other sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9D0B-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9D24-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma","valueDescription":"Pseudomyogenic Hemangioendothelioma","ValueMeaning":{"publicId":"4826496","version":"1","preferredName":"Pseudomyogenic Hemangioendothelioma","longName":"4826496","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm that more frequently affects young adult males and usually arises in the lower limbs.  In approximately half of the affected patients the tumor is painful and in two-thirds of the patients the tumor is multifocal.  Morphologically it is characterized by the presence of sheets and fascicles of spindle cells with abundant eosinophilic cytoplasm and vesicular nuclei.  Cytologic atypia is usually mild.  Approximately 60% of the patients develop local recurrences or additional tumors in the same anatomic region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudomyogenic Hemangioendothelioma","conceptCode":"C121668","definition":"An intermediate, rarely metastasizing blood vessel neoplasm that more frequently affects young adult males and usually arises in the lower limbs.  In approximately half of the affected patients the tumor is painful and in two-thirds of the patients the tumor is multifocal.  Morphologically it is characterized by the presence of sheets and fascicles of spindle cells with abundant eosinophilic cytoplasm and vesicular nuclei.  Cytologic atypia is usually mild.  Approximately 60% of the patients develop local recurrences or additional tumors in the same anatomic region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9D30-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9D49-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Solitary circumscribed neuroma","valueDescription":"Solitary Circumscribed Neuroma","ValueMeaning":{"publicId":"4826499","version":"1","preferredName":"Solitary Circumscribed Neuroma","longName":"4826499","preferredDefinition":"A benign peripheral nerve sheath tumor characterized by the presence of Schwann cells, axons, and perineurial fibroblasts.  It usually arises from the skin of the head and neck or the oral mucosa.  It presents as a solitary and painless nodular mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solitary Circumscribed Neuroma","conceptCode":"C121681","definition":"A benign peripheral nerve sheath tumor characterized by the presence of Schwann cells, axons, and perineurial fibroblasts.  It usually arises from the skin of the head and neck or the oral mucosa.  It presents as a solitary and painless nodular mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9D7B-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9D94-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Subungual exostosis","valueDescription":"Subungual Exostosis","ValueMeaning":{"publicId":"4826500","version":"1","preferredName":"Subungual Exostosis","longName":"4826500","preferredDefinition":"A benign lesion that affects the distal phalanx, most often the great toe.  Grossly it consists of a cartilage cap and a bony stalk.  Microscopically it is characterized by an osteochondromatous proliferation with a gradual transition of a peripheral spindle-cell proliferation to hyaline cartilage to trabecular bone.  Pain and swelling are present.  Simple resection is usually curative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subungual Exostosis","conceptCode":"C121844","definition":"A benign tumor that affects the distal phalanx, most often the great toe. Grossly it consists of a cartilage cap and a bony stalk. Microscopically it is characterized by an osteochondromatous proliferation with a gradual transition of a peripheral spindle-cell proliferation to hyaline cartilage to trabecular bone. Pain and swelling are present. Simple resection is usually curative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9DA0-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9DB9-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Undifferentiated epithelioid sarcoma","valueDescription":"Undifferentiated Epithelioid Sarcoma","ValueMeaning":{"publicId":"4826501","version":"1","preferredName":"Undifferentiated Epithelioid Sarcoma","longName":"4826501","preferredDefinition":"An undifferentiated soft tissue sarcoma characterized by the presence of a malignant cellular infiltrate with epithelioid morphology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Epithelioid Sarcoma","conceptCode":"C121802","definition":"An undifferentiated soft tissue sarcoma characterized by the presence of a malignant cellular infiltrate with epithelioid morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9DC5-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9DDE-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Undifferentiated round cell sarcoma","valueDescription":"Undifferentiated Round Cell Sarcoma","ValueMeaning":{"publicId":"4826502","version":"1","preferredName":"Undifferentiated Round Cell Sarcoma","longName":"4826502","preferredDefinition":"An undifferentiated soft tissue sarcoma characterized by the presence of uniform round or ovoid malignant cells with a high nuclear to cytoplasmic ratio.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Round Cell Sarcoma","conceptCode":"C121799","definition":"An undifferentiated soft tissue sarcoma characterized by the presence of uniform round or ovoid malignant cells with a high nuclear to cytoplasmic ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9DEA-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9E03-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Undifferentiated sarcoma NOS","valueDescription":"Undifferentiated Sarcoma, Not Otherwise Specified","ValueMeaning":{"publicId":"4826503","version":"1","preferredName":"Undifferentiated Sarcoma, Not Otherwise Specified","longName":"4826503","preferredDefinition":"An undifferentiated soft tissue sarcoma which cannot be further characterized.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Sarcoma, Not Otherwise Specified","conceptCode":"C121804","definition":"An undifferentiated soft tissue sarcoma which cannot be further characterized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9E0F-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9E28-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Spindle cell / Sclerosing rhabdomyosarcoma","valueDescription":"Spindle Cell/Sclerosing Rhabdomyosarcoma","ValueMeaning":{"publicId":"4826504","version":"1","preferredName":"Spindle Cell/Sclerosing Rhabdomyosarcoma","longName":"4826504","preferredDefinition":"An uncommon variant of rhabdomyosarcoma with spindle cell or sclerosing morphology.  It affects both children and adults and it is more common in males.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spindle Cell/Sclerosing Rhabdomyosarcoma","conceptCode":"C121654","definition":"An uncommon variant of rhabdomyosarcoma with spindle cell or sclerosing morphology.  It affects both children and adults and it is more common in males.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1612E956-9E62-A063-E050-BB89AD433DEA","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1612E956-9E7B-A063-E050-BB89AD433DEA","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"},{"value":"Benign notochordal tumor","valueDescription":"Benign Notochordal Cell Tumor","ValueMeaning":{"publicId":"4826701","version":"1","preferredName":"Benign Notochordal Cell Tumor","longName":"4826701","preferredDefinition":"An intraosseous benign tumor of notochord origin that arises in the bones of the base of the skull, vertebral bodies, or sacrococcygeal bones.  It contains vacuolated tumor cells without atypia, but lacks myxoid matrix, necrosis, and lobular architecture, which are features that characterize its malignant counterpart, chordoma.  Most lesions are incidental findings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Notochordal Cell Tumor","conceptCode":"C121901","definition":"An intraosseous benign tumor of notochord origin that arises in the bones of the base of the skull, vertebral bodies, sacrum or coccyx.  It contains vacuolated tumor cells without atypia, but lacks myxoid matrix, necrosis, and lobular architecture, which are features that characterize its malignant counterpart, chordoma.  Most lesions are incidental findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1620B38F-85ED-4691-E050-BB89AD4360C9","latestVersionIndicator":"Yes","beginDate":"2015-05-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1620B38F-8606-4691-E050-BB89AD4360C9","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-15","modifiedBy":"ONEDATA","dateModified":"2015-05-15","deletedIndicator":"No"},{"value":"Angiomatoid fibrous histiocytoma","valueDescription":"Angiomatoid Fibrous Histiocytoma","ValueMeaning":{"publicId":"4824503","version":"1","preferredName":"Angiomatoid Fibrous Histiocytoma","longName":"4824503","preferredDefinition":"A low malignant potential soft tissue neoplasm of uncertain differentiation.  It typically affects young patients, presenting as a slowly growing nodular or cystic tumor mass, most often in the subcutaneous tissues of the extremities.  Occasionally, patients have systemic symptoms (anemia, fever, and weight loss).  This tumor has a relatively good prognosis.  A minority of patients develop local recurrences.  Metastases are rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiomatoid Fibrous Histiocytoma","conceptCode":"C6494","definition":"A low malignant potential soft tissue neoplasm of uncertain differentiation.  It typically affects young patients, presenting as a slowly growing nodular or cystic tumor mass, most often in the subcutaneous tissues of the extremities.  Occasionally, patients have systemic symptoms (anemia, fever, and weight loss).  This tumor has a relatively good prognosis.  A minority of patients develop local recurrences.  Metastases are rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4B95-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4BAE-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Atypical fibroxanthoma","valueDescription":"Atypical Fibroxanthoma","ValueMeaning":{"publicId":"4824504","version":"1","preferredName":"Atypical Fibroxanthoma","longName":"4824504","preferredDefinition":"An intermediate cutaneous mesenchymal neoplasm of uncertain differentiation, usually affecting the actinic-damaged skin of the elderly.  The tumor presents as a single cutaneous nodule which is often ulcerated.  Microscopically, it is characterized by the presence of highly atypical cytologic features, pleomorphism and abundant mitotic figures. The vast majority of patients have an excellent prognosis following conservative therapy. Recurrences are infrequent, and metastasis is rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Fibroxanthoma","conceptCode":"C4246","definition":"An intermediate cutaneous mesenchymal neoplasm of uncertain differentiation, usually affecting the actinic-damaged skin of the elderly.  The tumor presents as a single cutaneous nodule which is often ulcerated.  Microscopically, it is characterized by the presence of highly atypical cytologic features, pleomorphism and abundant mitotic figures. The vast majority of patients have an excellent prognosis following conservative therapy. Recurrences are infrequent, and metastasis is rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4BB8-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4BD0-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Ectopic hamartomatous thymoma","valueDescription":"Ectopic Hamartomatous Thymoma","ValueMeaning":{"publicId":"4824507","version":"1","preferredName":"Ectopic Hamartomatous Thymoma","longName":"4824507","preferredDefinition":"A benign, well circumscribed tumor of the neck occurring in adults.  It is characterized by the presence of spindle cells, epithelial islands, and adipose tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Branchioma","conceptCode":"C53595","definition":"A rare, benign, well-circumscribed or encapsulated tumor that arises from the neck and occurs in adults. It is characterized by the presence of spindle cells, epithelial islands, and adipose tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4C01-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4C1A-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Pleomorphic hyalinizing angiectatic tumor","valueDescription":"Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts","ValueMeaning":{"publicId":"4824509","version":"1","preferredName":"Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts","longName":"4824509","preferredDefinition":"A non-metastasizing soft tissue neoplasm characterized by the presence of a neoplastic stroma containing spindle cells, dilated thin-walled vessels lined by fibrin, and a chronic inflammatory infiltrate.  The majority of cases develop in the subcutaneous tissues usually in the lower extremities and present as slow growing masses.  Recurrences occur in approximately half of the cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts","conceptCode":"C53594","definition":"A non-metastasizing soft tissue neoplasm characterized by the presence of a neoplastic stroma containing spindle cells, dilated thin-walled vessels lined by fibrin, and a chronic inflammatory infiltrate.  The majority of cases develop in the subcutaneous tissues usually in the lower extremities and present as slow growing masses.  Recurrences occur in approximately half of the cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4C27-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4C40-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Juxta-articular myxoma","valueDescription":"Juxta-Articular Myxoma","ValueMeaning":{"publicId":"4824513","version":"1","preferredName":"Juxta-Articular Myxoma","longName":"4824513","preferredDefinition":"A cellular myxoma arising from the joints.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juxta-Articular Myxoma","conceptCode":"C6580","definition":"A rare myxoma that usually arises in an area close to a large joint.  Morphologically it resembles a cellular myxoma.  In contrast to an intramuscular myxoma, it is not associated with mutations of the GNAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4C73-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4C8C-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Intramuscular myxoma (including cellular variant)","valueDescription":"Intramuscular Myxoma","ValueMeaning":{"publicId":"4824515","version":"1","preferredName":"Intramuscular Myxoma","longName":"4824515","preferredDefinition":"A myxoma arising from muscle tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramuscular Myxoma","conceptCode":"C6579","definition":"A benign, painless soft tissue tumor that arises in a muscle, usually in a large muscle of the thigh, buttocks, shoulder, or upper arm.  It is associated with point mutations of the GNAS gene.  Grossly it is characterized by a gelatinous and lobulated cut surface.  Morphologically it is composed of uniform spindled and stellate-shaped cells without atypia.  The cells are separated by myxoid stroma.  No recurrences have been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4C99-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4CB2-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Giant cell lesion of the small bones","valueDescription":"Giant Cell Lesion of Small Bones","ValueMeaning":{"publicId":"4826762","version":"1","preferredName":"Giant Cell Lesion of Small Bones","longName":"4826762","preferredDefinition":"A rare tumor-like lesion of the hands and feet characterized by the presence of hemorrhagic fibrous tissue, hemosiderin deposition, osteoclast-like giant cells which are irregularly distributed, and reactive bone formation.  Pain and swelling are the most frequent symptoms.  It may recur following curettage, but is usually cured after a second procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Lesion of Small Bones","conceptCode":"C121893","definition":"A rare tumor-like lesion of the hands and feet characterized by the presence of hemorrhagic fibrous tissue, hemosiderin deposition, osteoclast-like giant cells which are irregularly distributed, and reactive bone formation.  Pain and swelling are the most frequent symptoms.  It may recur following curettage, but is usually cured after a second procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1621E554-6C28-912E-E050-BB89AD4373B5","latestVersionIndicator":"Yes","beginDate":"2015-05-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1621E554-6C40-912E-E050-BB89AD4373B5","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-15","modifiedBy":"ONEDATA","dateModified":"2015-05-15","deletedIndicator":"No"},{"value":"Lipoma","valueDescription":"Lipoma","ValueMeaning":{"publicId":"2974460","version":"1","preferredName":"Lipoma","longName":"2974460","preferredDefinition":"A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipoma","conceptCode":"C3192","definition":"A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F041-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15E87403-A66E-CD32-E050-BB89AD430E3D","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Werner syndrome","valueDescription":"Werner Syndrome","ValueMeaning":{"publicId":"4824452","version":"1","preferredName":"Werner Syndrome","longName":"4824452","preferredDefinition":"A rare, autosomal recessive syndrome caused by mutations in the WRN gene. It is characterized by the appearance of accelerated aging following puberty. It is associated with the development of diabetes mellitus, atherosclerosis, cataracts, and cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Werner Syndrome","conceptCode":"C3447","definition":"A rare, autosomal recessive syndrome caused by mutations in the WRN gene. It is characterized by the appearance of accelerated aging following puberty. It is associated with the development of diabetes mellitus, atherosclerosis, cataracts, and cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-444B-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4464-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Rothmund-Thomson syndrome","valueDescription":"Rothmund-Thomson Syndrome","ValueMeaning":{"publicId":"3211425","version":"1","preferredName":"Rothmund-Thomson Syndrome","longName":"3211425","preferredDefinition":"An autosomal recessive inherited syndrome usually caused by mutations in the RECQL4 gene. It is characterized by poikilodermatous skin changes, sparse hair, cataracts, small stature, skeletal abnormalities, and an increased predisposition to cancer, particularly osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rothmund-Thomson Syndrome","conceptCode":"C3335","definition":"An autosomal recessive inherited syndrome usually caused by mutations in the RECQL4 gene. It is characterized by poikilodermatous skin changes, sparse hair, cataracts, small stature, skeletal abnormalities, and an increased predisposition to cancer, particularly osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FBF5-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4478-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Retinoblastoma syndrome","valueDescription":"Hereditary Retinoblastoma","ValueMeaning":{"publicId":"4824454","version":"1","preferredName":"Hereditary Retinoblastoma","longName":"4824454","preferredDefinition":"An inherited malignant tumor that originates in the nuclear layer of the retina. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Retinoblastoma","conceptCode":"C8495","definition":"An inherited malignant tumor that originates in the nuclear layer of the retina. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities affecting the RB1 gene. Patients with the inherited form appear to be at increased risk for secondary non-ocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4486-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-449F-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Neurofibromatosis type 1","valueDescription":"Neurofibromatosis Type 1","ValueMeaning":{"publicId":"2962080","version":"1","preferredName":"Neurofibromatosis Type 1","longName":"2962080","preferredDefinition":"Type 1 (peripheral) neurofibromatosis (von Recklinghausen's disease), is the most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath neoplasms, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 1","conceptCode":"C3273","definition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A8D-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"GDEEN","dateModified":"2023-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-44A9-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Multiple osteochondromas","valueDescription":"Multiple Osteochondromas","ValueMeaning":{"publicId":"3211273","version":"1","preferredName":"Multiple Osteochondromas","longName":"3211273","preferredDefinition":"A neoplastic chondrogenic process affecting multiple sites. Grossly and microscopically it resembles an osteochondroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Osteochondromas","conceptCode":"C53457","definition":"An autosomal dominant neoplastic chondrogenic process affecting multiple sites. It is caused by mutations in the EXT1 or EXT2 genes.  Grossly and microscopically, the lesions resemble an osteochondroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E6A1-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-44BD-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Li-Fraumeni syndrome","valueDescription":"Li-Fraumeni Syndrome","ValueMeaning":{"publicId":"3211225","version":"1","preferredName":"Li-Fraumeni Syndrome","longName":"3211225","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by an alteration in the p53 tumor suppressor gene.  It is characterized by the development of malignant neoplasms at various anatomic sites.  The malignant neoplasms associated with Li-Fraumeni syndrome include adrenal cortex carcinoma, astrocytic tumors, colorectal carcinoma, gastric carcinoma, malignant breast neoplasms, medulloblastoma, osteosarcoma, and soft tissue sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Li-Fraumeni Syndrome","conceptCode":"C3476","definition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the TP53 gene. It is associated with breast carcinoma, choroid plexus carcinoma, adrenal cortex carcinoma, astrocytic tumors, medulloblastoma, soft tissue sarcoma, osteosarcoma, and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DF6B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-44D2-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Maffucci syndrome","valueDescription":"Maffucci Syndrome","ValueMeaning":{"publicId":"4824456","version":"1","preferredName":"Maffucci Syndrome","longName":"4824456","preferredDefinition":"A rare non-inherited disorder primarily affecting the skin and skeletal system. It is classified as a mesodermal dysplasia. Clinical signs appear within the first decade and are characterized by multiple soft tissue hemiangiomas and enchondromas leading to skeletal deformities. Clinical course is progressive with variable development of associated malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maffucci Syndrome","conceptCode":"C3213","definition":"A rare non-inherited disorder primarily affecting the skin and skeletal system. It is classified as a mesodermal dysplasia. Clinical signs appear within the first decade and are characterized by multiple soft tissue hemiangiomas and enchondromas leading to skeletal deformities. Clinical course is progressive with variable development of associated malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-44E0-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-44F9-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Cherubism","valueDescription":"Cherubism","ValueMeaning":{"publicId":"3210953","version":"1","preferredName":"Cherubism","longName":"3210953","preferredDefinition":"A rare disorder usually caused by mutations in the SH3BP2 gene. It is characterized by prominence of the lower part of the face due to bilateral replacement of the mandible or maxilla bones by excessive fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cherubism","conceptCode":"C84630","definition":"A rare autosomal dominant inherited disorder usually caused by mutations in the SH3BP2 gene. It is characterized by a prominent lower part of the face due to bilateral replacement of the mandibular or maxillary bones by lesions. The lesions contain osteoclast-like cells admixed with spindle-shaped mononuclear stromal cells.  With time, the lesions become more fibrotic and less osteoclast-rich.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B930-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-450E-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann syndrome","valueDescription":"Beckwith-Wiedemann Syndrome","ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4519-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Epithelioid hemangioendothelioma","valueDescription":"Epithelioid Hemangioendothelioma","ValueMeaning":{"publicId":"3179346","version":"1","preferredName":"Epithelioid Hemangioendothelioma","longName":"3179346","preferredDefinition":"A low grade malignant blood vessel neoplasm characterized by the presence of epithelioid endothelial cells, hylanized and myxoid stroma formation, and angiocentricity. It may present as a painful mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Hemangioendothelioma","conceptCode":"C3800","definition":"A low-grade malignant blood vessel neoplasm.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-83D3-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-452D-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chordoma","valueDescription":"Chordoma","ValueMeaning":{"publicId":"3179237","version":"1","preferredName":"Chordoma","longName":"3179237","preferredDefinition":"A malignant bone tumor arising from the remnants of the fetal notochord. Although it can occur at all ages, it is more frequently seen in middle-aged adults. Most frequent sites of involvement are: sacrococcygeal area, spheno-occipital area, and the cervico-thoraco-lumbar spine. Microscopically, chordomas are composed of cells that form cords and lobules, separated by mucoid intercellular tissue. Some of the cells are large (physaliphorous) and have vacuolated cytoplasm and prominent vesicular nuclei. Other tumor cells are small with small nuclei without visible nucleoli. Chordomas tend to recur and may metastasize. The most common sites of metastasis are skin and bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chordoma","conceptCode":"C2947","definition":"A malignant bone tumor arising from the remnants of the fetal notochord. Although it can occur at all ages, it is more frequently seen in middle-aged adults. The most frequent sites of involvement are the sacrococcygeal area, spheno-occipital area, and cervico-thoraco-lumbar spine. Chordomas tend to recur and may metastasize. The most common sites of metastasis are lung, bone, lymph nodes, and subcutaneous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CDC6-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"SOKKERL","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-454C-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Benign fibrous histiocytoma / non-ossifying fibroma","valueDescription":"Benign Fibrous Histiocytoma of Bone","ValueMeaning":{"publicId":"4824459","version":"1","preferredName":"Benign Fibrous Histiocytoma of Bone","longName":"4824459","preferredDefinition":"A rare benign neoplasm arising from bone.  It is characterized by the presence of fibroblastic spindle cells arranged in a whorled storiform pattern, osteoclast-like giant cells, foam cells, inflammatory cells, hemosiderin deposition and stromal hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrous Histiocytoma of Bone","conceptCode":"C53963","definition":"A rare, benign neoplasm usually arising from the non-metaphyseal regions of long bones or pelvis. It is characterized by the presence of fibroblastic spindle cells arranged in a whorled storiform pattern, osteoclast-like giant cells, foam cells, inflammatory cells, hemosiderin deposition and stromal hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-457C-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4595-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignancy in giant cell tumor of bone","valueDescription":"Malignant Giant Cell Tumor of Bone","ValueMeaning":{"publicId":"3179358","version":"1","preferredName":"Malignant Giant Cell Tumor of Bone","longName":"3179358","preferredDefinition":"A high grade aggressive bone tumor, usually arising in the end of long bones. The tumor is composed of round or oval mononuclear cells, uniformly distributed osteoclast-like giant cells, and a sarcomatous spindle cell component. Clinical presentation includes pain and edema in the affected area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignancy in Giant Cell Tumor of Bone","conceptCode":"C4304","definition":"A malignant tumor that arises from the bone.  It is characterized by the presence of an area of high grade sarcoma in an otherwise typical giant cell tumor (primary malignancy in giant cell tumor), or the presence of sarcoma in which the pre-existing giant cell tumor may or may not be apparent (secondary malignancy in giant cell tumor).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-858B-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-45A9-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Giant cell tumor of bone","valueDescription":"Giant Cell Tumor of Bone","ValueMeaning":{"publicId":"4824461","version":"1","preferredName":"Giant Cell Tumor of Bone","longName":"4824461","preferredDefinition":"A benign or malignant bone tumor, usually arising in the end of long bones or the vertebrae. The tumor is composed of round or oval mononuclear cells and uniformly distributed osteoclast-like giant cells. Clinical presentation includes pain, edema, and decreased range of motion in the affected joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoclastic Giant Cell-Rich Tumor of Bone","conceptCode":"C3738","definition":"A benign, intermediate, or malignant bone tumor characterized by the presence of osteoclast-like giant cells. Clinical presentation includes pain, edema, and decreased range of motion in the affected joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-45B6-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-45CF-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"High-grade surface osteosarcoma","valueDescription":"High Grade Surface Osteosarcoma","ValueMeaning":{"publicId":"3179370","version":"1","preferredName":"High Grade Surface Osteosarcoma","longName":"3179370","preferredDefinition":"A usually aggressive high grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Surface Osteosarcoma","conceptCode":"C53958","definition":"A usually aggressive high grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8784-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4606-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Periosteal osteosarcoma","valueDescription":"Periosteal Osteosarcoma","ValueMeaning":{"publicId":"3179365","version":"1","preferredName":"Periosteal Osteosarcoma","longName":"3179365","preferredDefinition":"An intermediate grade malignant bone-forming mesenchymal neoplasm with chondroblastic differentiation.  The tumor arises from the surface of the bone and affects the diaphysis or diaphyseal- metaphyseal portion of the long bones.  A painless mass or swelling is the most common clinical sign.  It is associated with a better prognosis than conventional osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Periosteal Osteosarcoma","conceptCode":"C8970","definition":"An intermediate grade malignant bone-forming mesenchymal neoplasm with chondroblastic differentiation.  It arises from the surface of the bone and affects the diaphysis or diaphyseal- metaphyseal portion of the long bones.  A painless mass or swelling is the most common clinical sign.  It is associated with a better prognosis than conventional osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-86A3-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4610-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Parosteal osteosarcoma","valueDescription":"Parosteal Osteosarcoma","ValueMeaning":{"publicId":"3179364","version":"1","preferredName":"Parosteal Osteosarcoma","longName":"3179364","preferredDefinition":"A low grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone. It usually affects the distal posterior femur, the proximal tibia, and proximal humerus. Painless swelling is the usual clinical sign. Most patients are young adults and the prognosis is usually excellent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parosteal Osteosarcoma","conceptCode":"C8969","definition":"A low grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone. It usually affects the distal posterior femur, the proximal tibia, and proximal humerus. Painless swelling is the usual clinical sign. Most patients are young adults and the prognosis is usually excellent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-867E-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4624-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Secondary osteosarcoma","valueDescription":"Secondary Osteosarcoma","ValueMeaning":{"publicId":"3123902","version":"1","preferredName":"Secondary Osteosarcoma","longName":"3123902","preferredDefinition":"An osteosarcoma arising from a pre-existing lesion of the bone, usually Paget disease, or due to radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary Osteosarcoma","conceptCode":"C53704","definition":"An osteosarcoma arising from a pre-existing lesion of the bone, usually Paget disease, or due to radiation therapy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4310-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4638-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Small cell osteosarcoma","valueDescription":"Small Cell Osteosarcoma","ValueMeaning":{"publicId":"3179368","version":"1","preferredName":"Small Cell Osteosarcoma","longName":"3179368","preferredDefinition":"An osteosarcoma usually arising from the metaphysis of long bones. It is characterized by the presence of small cells and osteoid production. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Osteosarcoma","conceptCode":"C4023","definition":"An osteosarcoma usually arising from the metaphysis of long bones. It is characterized by the presence of small cells and osteoid production. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-873A-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4642-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Telangiectatic osteosarcoma","valueDescription":"Telangiectatic Osteosarcoma","ValueMeaning":{"publicId":"3179371","version":"1","preferredName":"Telangiectatic Osteosarcoma","longName":"3179371","preferredDefinition":"An osteosarcoma usually arising in the metaphysis of long bones. It is characterized by the presence of a cystic architecture with blood-filled spaces. The prognosis is similar to that of conventional osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Telangiectatic Osteosarcoma","conceptCode":"C3902","definition":"An osteosarcoma usually arising from the metaphysis of long bones. It is characterized by the presence of a cystic architecture with blood-filled spaces. The prognosis is similar to that of conventional osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-87A9-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-464C-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Osteoblastic osteosarcoma","valueDescription":"Osteoblastic Osteosarcoma","ValueMeaning":{"publicId":"4824464","version":"1","preferredName":"Osteoblastic Osteosarcoma","longName":"4824464","preferredDefinition":"A conventional osteosarcoma characterized by the predominance of osteoid matrix.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoblastic Osteosarcoma","conceptCode":"C53953","definition":"A conventional osteosarcoma characterized by the predominance of osteoid matrix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4659-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4672-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Fibroblastic osteosarcoma","valueDescription":"Fibroblastic Osteosarcoma","ValueMeaning":{"publicId":"4824466","version":"1","preferredName":"Fibroblastic Osteosarcoma","longName":"4824466","preferredDefinition":"A conventional osteosarcoma characterized by the presence of spindle shaped cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibroblastic Osteosarcoma","conceptCode":"C4020","definition":"A conventional osteosarcoma characterized by the presence of spindle shaped cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-467F-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4698-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chondroblastic osteosarcoma","valueDescription":"Chondroblastic Osteosarcoma","ValueMeaning":{"publicId":"4824468","version":"1","preferredName":"Chondroblastic Osteosarcoma","longName":"4824468","preferredDefinition":"An osteosarcoma characterised by the presence of atypical cartilage of variable cellularity.  It may or may not be associated with the presence of myxoid areas or focal bone formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondroblastic Osteosarcoma","conceptCode":"C4021","definition":"An osteosarcoma characterised by the presence of atypical cartilage of variable cellularity.  It may or may not be associated with the presence of myxoid areas or focal bone formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-46A5-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-46BE-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Conventional osteosarcoma","valueDescription":"Conventional Osteosarcoma","ValueMeaning":{"publicId":"3179339","version":"1","preferredName":"Conventional Osteosarcoma","longName":"3179339","preferredDefinition":"A high grade malignant bone-forming mesenchymal neoplasm producing osteoid. The tumor arises from the medullary portion of the bone. It affects the long bones and most commonly, the distal femur, proximal tibia, and proximal humerus. Pain with or without a palpable mass is the most common clinical presentation. It usually has an aggressive growth and may metastasize through the hematogenous route. The lung is the most frequent site of metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conventional Osteosarcoma","conceptCode":"C35870","definition":"A high grade malignant bone-forming mesenchymal neoplasm producing osteoid. The tumor arises from the medullary portion of the bone. It affects the long bones and most commonly, the distal femur, proximal tibia, and proximal humerus. Pain with or without a palpable mass is the most common clinical presentation. It usually has an aggressive growth and may metastasize through the hematogenous route. The lung is the most frequent site of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-82C8-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-46D2-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Low-grade central osteosarcoma","valueDescription":"Low Grade Central Osteosarcoma","ValueMeaning":{"publicId":"3179355","version":"1","preferredName":"Low Grade Central Osteosarcoma","longName":"3179355","preferredDefinition":"A low grade osteosarcoma arising from the medullary portion of the bone. The tumor affects the long bones and is characterized by the presence of fibroblastic stroma and osteoid production. Pain and swelling are the usual sign and symptom. The prognosis is more favorable than conventional osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Central Osteosarcoma","conceptCode":"C6474","definition":"A low grade osteosarcoma arising from the medullary portion of the bone. It affects the long bones and is characterized by the presence of fibroblastic stroma and osteoid production. Pain and swelling are the usual sign and symptom. The prognosis is more favorable than conventional osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-851C-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-46E6-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Osteoblastoma","valueDescription":"Osteoblastoma","ValueMeaning":{"publicId":"3251714","version":"1","preferredName":"Osteoblastoma","longName":"3251714","preferredDefinition":"A rare benign bone-forming neoplasm usually arising from the spine. It is a well-circumscribed lytic tumor that varies in size. The tumor is composed of woven bone trabeculae and shares similar histologic characteristics with the osteoid osteoma. Surgical curettage is the treatment of choice. The prognosis is excellent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoblastoma","conceptCode":"C3294","definition":"A rare benign bone-forming neoplasm usually arising from the spine. It is a well-circumscribed lytic tumor that varies in size. The tumor is composed of woven bone trabeculae and shares similar histologic characteristics with the osteoid osteoma. Surgical curettage is the treatment of choice. The prognosis is excellent.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D68C-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-46F0-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Osteoid osteoma","valueDescription":"Osteoid Osteoma","ValueMeaning":{"publicId":"3251710","version":"1","preferredName":"Osteoid Osteoma","longName":"3251710","preferredDefinition":"A small benign bone-forming neoplasm characterized by the presence of differentiated osteoblasts. The tumor is usually surrounded by hypervascular sclerotic bone and has limited growth potential. Clinical signs and symptoms include pain and localized tenderness, at the site of the lesion. The pain may be intense, but in the majority of cases it is completely alleviated by aspirin. Prognosis is excellent and recurrences are rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoid Osteoma","conceptCode":"C3297","definition":"A small, benign, bone-forming neoplasm that can arise from any bone but more frequently affects the long bones. The central portion of the neoplasm (nidus) contains differentiated osteoblasts which produce osteoid and sometimes bone. The lesion is usually surrounded by hypervascular sclerotic bone and has limited growth potential. Clinical signs and symptoms include pain and localized tenderness, at the site of the lesion. The pain may be intense but in the majority of cases it is completely alleviated by non-steroidal anti-inflammatory drugs. Prognosis is excellent and recurrences are rare.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D640-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4704-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Osteoma","valueDescription":"Osteoma","ValueMeaning":{"publicId":"4824470","version":"1","preferredName":"Osteoma","longName":"4824470","preferredDefinition":"A rare, benign neoplasm arising from the bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoma","conceptCode":"C3296","definition":"A benign, well-circumscribed, bone-forming neoplasm predominantly composed of lamellar bone. It usually arises from the calvarial, facial, or jaw bones.  It is usually asymptomatic but it may cause local swelling or obstruction of the paranasal sinuses.  Asymptomatic cases have an indolent clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4711-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4729-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Benign","valueDescription":"Benign","ValueMeaning":{"publicId":"4824471","version":"1","preferredName":"Benign","longName":"4824471","preferredDefinition":"Not cancerous. Benign tumors may grow larger but do not spread to other parts of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4734-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-474C-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Clear cell chondrosarcoma","valueDescription":"Clear Cell Chondrosarcoma","ValueMeaning":{"publicId":"3179238","version":"1","preferredName":"Clear Cell Chondrosarcoma","longName":"3179238","preferredDefinition":"A rare usually low grade malignant mesenchymal neoplasm characterized by the presence of hyaline cartilage and clear cells. It usually arises in the epiphyseal ends of long bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Chondrosarcoma","conceptCode":"C6475","definition":"A rare, usually low grade chondrosarcoma characterized by the presence of tumor cells with clear cytoplasm. It usually arises in the epiphyseal ends of long bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CDEB-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4757-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Mesenchymal chondrosarcoma","valueDescription":"Mesenchymal Chondrosarcoma","ValueMeaning":{"publicId":"3179360","version":"1","preferredName":"Mesenchymal Chondrosarcoma","longName":"3179360","preferredDefinition":"A rare morphologic variant of chondrosarcoma. It is characterized by the presence of malignant small round cells, biphasic growth pattern, and well differentiated hyaline cartilage. Clinical presentation includes pain and swelling. The clinical course is aggressive, with local recurrences and distant metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesenchymal Chondrosarcoma","conceptCode":"C3737","definition":"A morphologic variant of chondrosarcoma arising from bone and soft tissue. It is characterized by the presence of malignant small round cells, biphasic growth pattern, and well differentiated hyaline cartilage. Clinical presentation includes pain and swelling. The clinical course is aggressive, with local recurrences and distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-85EA-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4761-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Dedifferentiated chondrosarcoma","valueDescription":"Dedifferentiated Chondrosarcoma","ValueMeaning":{"publicId":"3179340","version":"1","preferredName":"Dedifferentiated Chondrosarcoma","longName":"3179340","preferredDefinition":"An aggressive morphologic variant of chondrosarcoma. It is composed of a low grade chondrosarcoma and a high grade non-cartilagenous sarcomatous component. Due to the aggressive nature of the disease, its prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dedifferentiated Chondrosarcoma","conceptCode":"C6476","definition":"An aggressive morphologic variant of chondrosarcoma. It is composed of a low grade chondrosarcoma and a high grade non-cartilagenous sarcomatous component. Due to the aggressive nature of the disease, its prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-82ED-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-476B-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myxoid liposarcoma","valueDescription":"Myxoid/Round Cell Liposarcoma","ValueMeaning":{"publicId":"4264959","version":"1","preferredName":"Myxoid/Round Cell Liposarcoma","longName":"4264959","preferredDefinition":"A liposarcoma characterized by the presence of round non-lipogenic mesenchymal cells and small signet ring lipoblasts within a myxoid stoma with a vascular-branching pattern, or the presence of solid sheets of primitive round cells without myxoid stroma. The tumor is usually well-circumscribed. The majority of cases arise from within the thigh muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoid Liposarcoma","conceptCode":"C27781","definition":"A liposarcoma characterized by the presence of round non-lipogenic primitive mesenchymal cells and small signet ring lipoblasts within a myxoid stoma with a branching vascular pattern.  This category includes hypercellular lesions with round cell morphology, formerly known as round cell liposarcoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3ADA-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-AF36-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Dedifferentiated liposarcoma","valueDescription":"Dedifferentiated Liposarcoma","ValueMeaning":{"publicId":"4824331","version":"1","preferredName":"Dedifferentiated Liposarcoma","longName":"4824331","preferredDefinition":"An atypical lipomatous tumor/well differentiated liposarcoma that shows progression to a usually non-lipomatous, high grade sarcoma.  The non-lipomatous sarcoma component may be present in the primary lesion or at the site of recurrence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dedifferentiated Liposarcoma","conceptCode":"C3704","definition":"An atypical lipomatous tumor/well differentiated liposarcoma that shows progression to a usually non-lipomatous, high grade sarcoma.  The non-lipomatous sarcoma component may be present in the primary lesion or at the site of recurrence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-AF41-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-AF59-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Atypical lipomatous tumor / well differentiated liposarcoma","valueDescription":"Atypical Lipomatous Tumor","ValueMeaning":{"publicId":"4824333","version":"1","preferredName":"Atypical Lipomatous Tumor","longName":"4824333","preferredDefinition":"An intermediate, locally aggressive lipomatous neoplasm.  Microscopically, the adipose tissue contains large and pleomorphic lipoblasts, and is dissected by fibrous septa containing spindle cells.  It requires a wide local excision, may recur locally, but never metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Lipomatous Tumor/Well Differentiated Liposarcoma","conceptCode":"C6505","definition":"A locally aggressive mesenchymal neoplasm composed either entirely or partly of an adipocytic proliferation showing at least focal nuclear atypia in both adipocytes and stromal cells. \"Atypical lipomatous tumor\" and \"well-differentiated liposarcoma\" are synonyms describing lesions that are morphologically and genetically identical. Amplification of MDM2 and/or CDK4 is almost always present. (WHO 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-AF67-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-AF80-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Hibernoma","valueDescription":"Hibernoma","ValueMeaning":{"publicId":"4824335","version":"1","preferredName":"Hibernoma","longName":"4824335","preferredDefinition":"A rare benign slow growing adipose tissue tumor, characterized by the presence of polygonal brown fat cells with multivacuolated and/or granular cytoplasm.  The tumor is usually painless and is most often seen in young adults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hibernoma","conceptCode":"C3702","definition":"A rare benign slow growing adipose tissue tumor, characterized by the presence of polygonal brown fat cells with multivacuolated and/or granular cytoplasm.  The tumor is usually painless and is most often seen in young adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-AF8D-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-AFA5-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Angiolipoma","valueDescription":"Angiolipoma","ValueMeaning":{"publicId":"4824337","version":"1","preferredName":"Angiolipoma","longName":"4824337","preferredDefinition":"A lipoma with prominent vascularity. The vascular tissue is more abundant at the periphery of the tumor and contains fibrin thrombi. It occurs more frequently in younger individuals as a painful subcutaneous nodule, often on the arms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiolipoma","conceptCode":"C3733","definition":"A lipoma with prominent vascularity. The vascular tissue is more abundant at the periphery of the tumor and contains fibrin thrombi. It occurs more frequently in younger individuals as a painful subcutaneous nodule, often on the arms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-AFB3-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-AFCB-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chondroid lipoma","valueDescription":"Chondroid Lipoma","ValueMeaning":{"publicId":"4824339","version":"1","preferredName":"Chondroid Lipoma","longName":"4824339","preferredDefinition":"A rare benign adipose tissue neoplasm characterized by nests and cord of abundant univacuolated and multivacuolated lipoblasts and mature adipocytes in a prominent myxoid to hyalinized chondroid matrix admix. It predominantly affects females.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondroid Lipoma","conceptCode":"C6503","definition":"A rare benign adipose tissue neoplasm characterized by nests and cord of abundant univacuolated and multivacuolated lipoblasts and mature adipocytes in a prominent myxoid to hyalinized chondroid matrix admix. It predominantly affects females.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-AFD9-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-AFF2-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Extra-adrenal myelolipoma","valueDescription":"Extra-Adrenal Adrenal Gland Myelolipoma","ValueMeaning":{"publicId":"4824340","version":"1","preferredName":"Extra-Adrenal Adrenal Gland Myelolipoma","longName":"4824340","preferredDefinition":"Pertaining to tissues outside the adrenal gland.: A benign soft tissue lesion arising from the adrenal gland.  It is composed of mature adipose and hematopoietic/lymphoid tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extra-Adrenal","conceptCode":"C103852","definition":"Pertaining to tissues outside the adrenal gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Gland Myelolipoma","conceptCode":"C3736","definition":"A benign soft tissue lesion arising from the adrenal gland.  It is composed of mature adipose and hematopoietic/lymphoid tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-AFFF-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B018-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Extra-renal angiomyolipoma","valueDescription":"External Renal Angiomyolipoma","ValueMeaning":{"publicId":"4824341","version":"1","preferredName":"External Renal Angiomyolipoma","longName":"4824341","preferredDefinition":"Happening or arising or located outside or beyond some limits, or especially, some surface.: Of or pertaining to the kidney.: A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis.  It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue.  The kidney is the most common site of involvement.  Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum.  The vast majority of cases follow a benign clinical course.  However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"External","conceptCode":"C44280","definition":"Happening or arising or located outside or beyond some limits, or especially, some surface.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Angiomyolipoma","conceptCode":"C3734","definition":"A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis.  It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue.  The kidney is the most common site of involvement.  Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum.  The vast majority of cases follow a benign clinical course.  However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B026-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B03F-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Lipoblastoma","valueDescription":"Lipoblastoma","ValueMeaning":{"publicId":"4824343","version":"1","preferredName":"Lipoblastoma","longName":"4824343","preferredDefinition":"A lipoma usually occurring in the extremities of young children (usually boys). It is characterized by lobules of adipose tissue, separated by fibrous septa.  The adipose tissue is composed of mature adipocytes and lipoblasts. The lipoblasts may be scarce, depending on the age of the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipoblastoma","conceptCode":"C27483","definition":"A lipoma usually occurring in the extremities of young children (usually boys). It is characterized by lobules of adipose tissue, separated by fibrous septa.  The adipose tissue is composed of mature adipocytes and lipoblasts. The lipoblasts may be scarce, depending on the age of the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B04C-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B065-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Lipoblastomatosis","valueDescription":"Lipoblastomatosis","ValueMeaning":{"publicId":"4824345","version":"1","preferredName":"Lipoblastomatosis","longName":"4824345","preferredDefinition":"A benign disorder characterized by the presence of multiple lipoblastomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipoblastomatosis","conceptCode":"C4255","definition":"A neoplastic process characterized by the presence of multiple lipoblastomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B072-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B08B-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Lipomatosis","valueDescription":"Lipomatosis","ValueMeaning":{"publicId":"4824347","version":"1","preferredName":"Lipomatosis","longName":"4824347","preferredDefinition":"A neoplastic process characterized by diffuse overgrowth of mature adipose tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipomatosis","conceptCode":"C3193","definition":"A neoplastic process characterized by diffuse overgrowth of mature adipose tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B098-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B0B1-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Lipomatosis of nerve","valueDescription":"Lipomatosis of Nerve","ValueMeaning":{"publicId":"4824349","version":"1","preferredName":"Lipomatosis of Nerve","longName":"4824349","preferredDefinition":"A tumor composed of mature adipocytes and fibrous tissue infiltrating the epineurium and peripheral nerves.  It is often seen at birth or during childhood and may be associated with macrodactyly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipomatosis of Nerve","conceptCode":"C5431","definition":"A tumor composed of mature adipocytes and fibrous tissue infiltrating the epineurium and peripheral nerves.  It is often seen at birth or during childhood and may be associated with macrodactyly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B0BE-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B0D7-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myolipoma","valueDescription":"Myolipoma","ValueMeaning":{"publicId":"4824351","version":"1","preferredName":"Myolipoma","longName":"4824351","preferredDefinition":"A benign extrauterine tumor composed of mature adipocytes and smooth muscle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myolipoma","conceptCode":"C9502","definition":"A benign extrauterine tumor composed of mature adipocytes and smooth muscle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B0E4-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B0FD-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Spindle cell / pleomorphic lipoma","valueDescription":"Spindle Cell/Pleomorphic Lipoma","ValueMeaning":{"publicId":"4824353","version":"1","preferredName":"Spindle Cell/Pleomorphic Lipoma","longName":"4824353","preferredDefinition":"A benign lipomatous neoplasm characterized by the presence of an admixture of mature adipose tissue and bland spindle cells.  The pleomorphic variant contains in addition multinucleated giant cells.  It usually arises in the neck and upper trunk in older males.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spindle Cell/Pleomorphic Lipoma","conceptCode":"C7180","definition":"A benign lipomatous neoplasm characterized by the presence of an admixture of mature adipose tissue and bland spindle cells.  The pleomorphic variant contains in addition multinucleated giant cells.  It usually arises in the neck and upper trunk in older males.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B10A-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B123-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Lymphangioma","valueDescription":"Lymphangioma","ValueMeaning":{"publicId":"4824371","version":"1","preferredName":"Lymphangioma","longName":"4824371","preferredDefinition":"A benign lesion composed of dilated lymphatic channels. Painless swelling is the usual clinical manifestation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphangioma","conceptCode":"C8965","definition":"A benign lesion composed of dilated lymphatic channels. Painless swelling is the usual clinical manifestation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B12E-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B146-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Angiomatosis","valueDescription":"Angiomatosis","ValueMeaning":{"publicId":"4824373","version":"1","preferredName":"Angiomatosis","longName":"4824373","preferredDefinition":"A benign diffuse vascular proliferation usually occurring in young adults. It is characterized by the formation of capillary-sized and cavernous vascular spaces. Patients present with diffuse persistent swelling.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiomatosis","conceptCode":"C27503","definition":"A benign diffuse vascular proliferation usually occurring in young adults. It is characterized by the formation of capillary-sized and cavernous vascular spaces. Patients present with diffuse persistent swelling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B154-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B16D-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Arteriovenous hemangioma / malformation","valueDescription":"Arteriovenous Malformation","ValueMeaning":{"publicId":"3252169","version":"1","preferredName":"Arteriovenous Malformation","longName":"3252169","preferredDefinition":"Abnormal, tangled collections of dilated blood vessels that result from congenitally malformed vascular structures in which arterial afferents flow directly into venous efferents without the usual resistance of an intervening capillary bed. A common type is the congenital arteriovenous fistula (ARTERIOVENOUS FISTULA /congenital). For arteriovenous malformations in the brain, INTRACRANIAL ARTERIOVENOUS MALFORMATIONS is available. (From Merck Manual, 15th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arteriovenous Malformation/Hemangioma","conceptCode":"C2882","definition":"A benign vascular lesion characterized by the presence of a complex network of communicating arterial and venous vascular structures.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A78372C6-E375-4779-E040-BB89AD432A7F","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B181-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Venous hemangioma","valueDescription":"Venous Hemangioma","ValueMeaning":{"publicId":"4824375","version":"1","preferredName":"Venous Hemangioma","longName":"4824375","preferredDefinition":"A hemangioma composed of veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Venous Hemangioma","conceptCode":"C4296","definition":"A hemangioma composed of veins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B18E-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B1A7-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Synovial hemangioma","valueDescription":"Synovial Hemangioma","ValueMeaning":{"publicId":"4824377","version":"1","preferredName":"Synovial Hemangioma","longName":"4824377","preferredDefinition":"A rare hemangioma arising from synovium lining surfaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Hemangioma","conceptCode":"C6525","definition":"A rare hemangioma arising from synovium lining surfaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B1B4-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B1CD-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Pleomorphic rhabdomyosarcoma","valueDescription":"Pleomorphic Rhabdomyosarcoma","ValueMeaning":{"publicId":"3179366","version":"1","preferredName":"Pleomorphic Rhabdomyosarcoma","longName":"3179366","preferredDefinition":"An aggressive malignant mesenchymal neoplasm with skeletal muscle differentiation, occurring in adults and rarely in children.  The tumor is characterized by the presence of bizarre round, spindle, and polygonal cells.  Clinical presentation includes a rapidly enlarging painful mass usually of the lower extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Rhabdomyosarcoma","conceptCode":"C4258","definition":"An aggressive malignant mesenchymal neoplasm with skeletal muscle differentiation, occurring in adults and rarely in children.  The tumor is characterized by the presence of bizarre round, spindle, and polygonal cells.  Clinical presentation includes a rapidly enlarging painful mass usually of the lower extremities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-86C8-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B240-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Alveolar rhabdomyosarcoma","valueDescription":"Alveolar Rhabdomyosarcoma","ValueMeaning":{"publicId":"3179233","version":"1","preferredName":"Alveolar Rhabdomyosarcoma","longName":"3179233","preferredDefinition":"A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alveolar Rhabdomyosarcoma","conceptCode":"C3749","definition":"A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CD32-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B24A-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Embryonal rhabdomyosarcoma","valueDescription":"Embryonal Rhabdomyosarcoma","ValueMeaning":{"publicId":"4824381","version":"1","preferredName":"Embryonal Rhabdomyosarcoma","longName":"4824381","preferredDefinition":"A poorly circumscribed morphologic variant of rhabdomyosarcoma.  It is characterized by the presence of primitive skeletal muscle differentiation in any stage of myogenesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Rhabdomyosarcoma","conceptCode":"C8971","definition":"A poorly circumscribed morphologic variant of rhabdomyosarcoma.  It is characterized by the presence of primitive skeletal muscle differentiation in any stage of myogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B254-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B26C-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Rhabdomyoma","valueDescription":"Rhabdomyoma","ValueMeaning":{"publicId":"3251866","version":"1","preferredName":"Rhabdomyoma","longName":"3251866","preferredDefinition":"A benign neoplasm arising from striated muscle. It is characterized by the presence of rhabdomyoblasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyoma","conceptCode":"C3358","definition":"A benign mesenchymal tumor arising from skeletal or cardiac muscle.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A771271B-01A1-B6CD-E040-BB89AD436FA1","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B277-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Angioleiomyoma","valueDescription":"Angioleiomyoma","ValueMeaning":{"publicId":"4824383","version":"1","preferredName":"Angioleiomyoma","longName":"4824383","preferredDefinition":"A benign, slow-growing neoplasm that arises from the dermis or subcutaneous tissue. It is characterized by the presence of well-differentiated smooth muscle cells which are arranged around numerous vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angioleiomyoma","conceptCode":"C3747","definition":"A benign, slow-growing neoplasm that arises from the dermis or subcutaneous tissue. It is characterized by the presence of well-differentiated smooth muscle cells which are arranged around numerous vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B284-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B29D-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myofibromatosis","valueDescription":"Myofibromatosis","ValueMeaning":{"publicId":"3249531","version":"1","preferredName":"Myofibromatosis","longName":"3249531","preferredDefinition":"A benign neoplasm arising from the soft tissues. It is characterized by the presence of myofibroblastic hyperchromatic spindle cells, hylanized stroma formation, calcification, necrosis, and a multinodular growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myofibromatosis","conceptCode":"C3742","definition":"A benign, multifocal, nodular and well-circumscribed neoplasm usually seen as a congenital neoplasm or in the first year of life. It is characterized by a biphasic growth pattern and is composed of small, undifferentiated mesenchymal cells associated with branching thin-walled vessels and more mature neoplastic spindle cells with abundant eosinophilic cytoplasm in a collagenous stroma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-06ED-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B2B1-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chondrosarcoma","valueDescription":"Chondrosarcoma","ValueMeaning":{"publicId":"3179236","version":"1","preferredName":"Chondrosarcoma","longName":"3179236","preferredDefinition":"A malignant mesenchymal tumor arising from cartilage-forming tissues involving the bones.  It affects middle-aged to elderly adults, and the pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement.  Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondrosarcoma","conceptCode":"C2946","definition":"A malignant cartilaginous matrix-producing mesenchymal neoplasm arising from the bone and soft tissue.  It usually affects middle-aged to elderly adults.  The pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement.  Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CDA1-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-47BB-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chondroblastoma","valueDescription":"Chondroblastoma","ValueMeaning":{"publicId":"4264839","version":"1","preferredName":"Chondroblastoma","longName":"4264839","preferredDefinition":"A benign, lytic neoplasm usually arising from the cartilage in epiphysis and metaphysis of bone.  It is a well circumscribed tumor characterized by the presence of chondroblasts, osteoclast-like giant cells, myxoid stroma formation, calcification, and mitotic activity. In aggressive cases, there is rearrangement of the 8q21 chromosome band.  The tumor occurs most frequently in children and young adults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondroblastoma","conceptCode":"C2945","definition":"A benign, chondroid-producing, well-circumscribed, lytic neoplasm usually arising from the epiphysis of long bones.  It is characterized by the presence of chondroblasts, osteoclast-like giant cells, chondroid formation, calcification, and mitotic activity. In aggressive cases, there is rearrangement of the 8q21 chromosome band.  It occurs most frequently in children and young adults and rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42F0-002F-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-47CF-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Atypical cartilaginous tumor / chondrosarcoma grade I","valueDescription":"Well Differentiated Chondrosarcoma","ValueMeaning":{"publicId":"4824475","version":"1","preferredName":"Well Differentiated Chondrosarcoma","longName":"4824475","preferredDefinition":"A low grade malignant chondrogenic neoplasm characterized by pure hyaline cartilage differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1","conceptCode":"C9027","definition":"A low-grade chondrosarcoma characterized by the presence of moderate cellularity, hyperchromatic and plump nuclei of uniform size, and occasional binucleated cells.  Mitotic figures are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-47DD-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-47F6-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chondromyxoid fibroma","valueDescription":"Chondromyxoid Fibroma","ValueMeaning":{"publicId":"3249216","version":"1","preferredName":"Chondromyxoid Fibroma","longName":"3249216","preferredDefinition":"An uncommon benign neoplasm arising from the bone. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells. It has been associated with chromosomal rearrangement of 6q13 and 6q25 bands. The most common clinical symptom is mild, localized pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondromyxoid Fibroma","conceptCode":"C3830","definition":"An uncommon benign cartilaginous neoplasm arising from the bone. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells. It has been associated with chromosomal rearrangement of 6q13 and 6q25 bands. The most common clinical symptom is mild, localized pain.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1C67-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-480A-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Synovial chondromatosis","valueDescription":"Synovial Chondromatosis","ValueMeaning":{"publicId":"4824477","version":"1","preferredName":"Synovial Chondromatosis","longName":"4824477","preferredDefinition":"An uncommon, benign cartilaginous neoplasm usually occurring in adults.  The nodular tumor arises from the synovial membranes of joints.  It is characterized by the presence of chondrocytes, nuclear pleomorphism, and hyaline cartilage differentiation.  Clinical presentation may include joint pain, swelling, and limited range of motion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Chondromatosis","conceptCode":"C34467","definition":"An uncommon, benign cartilaginous neoplasm usually occurring in adults.  The nodular tumor arises from the synovial membranes of joints.  It is characterized by the presence of chondrocytes, nuclear pleomorphism, and hyaline cartilage differentiation.  Clinical presentation may include joint pain, swelling, and limited range of motion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4817-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4830-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Periosteal chondroma","valueDescription":"Periosteal Chondroma","ValueMeaning":{"publicId":"4824482","version":"1","preferredName":"Periosteal Chondroma","longName":"4824482","preferredDefinition":"A benign neoplasm composed of hyaline cartilage arising from the periosteum of the bone. It is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Periosteal Chondroma","conceptCode":"C4302","definition":"A benign neoplasm of bone surface composed of hyaline cartilage.  It arises beneath the periosteum and is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-48A6-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-48BF-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Enchondroma","valueDescription":"Enchondroma","ValueMeaning":{"publicId":"4824484","version":"1","preferredName":"Enchondroma","longName":"4824484","preferredDefinition":"A common benign neoplasm arising in the intramedullary bone.  It is characterized by the presence of chondrocytes, low mitotic activity, and in some cases, a nodular pattern and calcification. The small bones of the hands and feet are the most frequently affected sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enchondroma","conceptCode":"C3007","definition":"A common benign hyaline cartilage neoplasm arising in the intramedullary bone.  It is characterized by the presence of chondrocytes, low mitotic activity, and in some cases, a nodular pattern and calcification. The small bones of the hands and feet are the most frequently affected sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-48CC-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-48E5-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Chondroma","valueDescription":"Chondroma","ValueMeaning":{"publicId":"4824486","version":"1","preferredName":"Chondroma","longName":"4824486","preferredDefinition":"A benign well circumscribed neoplasm arising from the hyaline cartilage in soft tissue or bone. It is characterized by the presence of chondrocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondroma","conceptCode":"C53459","definition":"A benign well circumscribed neoplasm of hyaline cartilage arising from bone or soft tissue. It is characterized by the presence of chondrocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-48F2-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-490A-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Osteochondroma","valueDescription":"Osteochondroma","ValueMeaning":{"publicId":"3251712","version":"1","preferredName":"Osteochondroma","longName":"3251712","preferredDefinition":"A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteochondroma","conceptCode":"C3295","definition":"A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D666-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4915-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Undifferentiated pleomorphic sarcoma","valueDescription":"Unclassified Pleomorphic Sarcoma","ValueMeaning":{"publicId":"4417403","version":"1","preferredName":"Unclassified Pleomorphic Sarcoma","longName":"4417403","preferredDefinition":"A pleomorphic sarcoma characterized by the presence of fibrohistiocytic cells and spindle cells arranged in a storiform pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Pleomorphic Sarcoma","conceptCode":"C4247","definition":"An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate.  It is also known as malignant fibrous histiocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF69122E-9D72-60EF-E040-BB89AD436B90","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4951-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Undifferentiated spindle cell sarcoma","valueDescription":"Undifferentiated Pancreatic Carcinoma","ValueMeaning":{"publicId":"3402724","version":"1","preferredName":"Undifferentiated Pancreatic Carcinoma","longName":"3402724","preferredDefinition":"A carcinoma with poor prognosis that arises from the pancreas.  It is characterized by the presence of a significant malignant component that does not show differentiation.  The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Undifferentiated Carcinoma","conceptCode":"C5722","definition":"A carcinoma with poor prognosis that arises from the pancreas.  It is characterized by the presence of a significant malignant component that does not show differentiation.  The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA85A70C-EE2E-7C6C-E040-BB89AD430169","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4965-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Intimal sarcoma","valueDescription":"Intimal Sarcoma","ValueMeaning":{"publicId":"3123928","version":"1","preferredName":"Intimal Sarcoma","longName":"3123928","preferredDefinition":"A malignant neoplasm arising from the large blood vessels.  It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels.  The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intimal Sarcoma","conceptCode":"C53677","definition":"A malignant neoplasm arising from the large blood vessels.  It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels.  The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs.  The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4538-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-496F-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Neoplasms with perivascular epithelioid cell differentiation (PEComa)","valueDescription":"Neoplasm with Perivascular Epithelioid Cell Differentiation","ValueMeaning":{"publicId":"4824490","version":"1","preferredName":"Neoplasm with Perivascular Epithelioid Cell Differentiation","longName":"4824490","preferredDefinition":"A soft tissue neoplasm composed of perivascular epithelioid cells.  Representative examples include angiomyolipoma, clear cell-sugar-tumor of the lung, and lymphangioleiomyomatosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PEComa","conceptCode":"C38150","definition":"A soft tissue mesenchymal tumor with perivascular epithelioid cell differentiation. Representative examples include angiomyolipoma, clear cell-sugar-tumor of the lung, and lymphangioleiomyomatosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-49C2-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-49DB-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Extrarenal rhabdoid tumor","valueDescription":"Extrarenal Rhabdoid Tumor","ValueMeaning":{"publicId":"3123860","version":"1","preferredName":"Extrarenal Rhabdoid Tumor","longName":"3123860","preferredDefinition":"A rhabdoid tumor which arises in the soft tissues.  It occurs in infants and children and may be associated with loss of chromosome 22.  It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extrarenal Rhabdoid Tumor","conceptCode":"C6586","definition":"A rhabdoid tumor which arises in the soft tissues.  It occurs in infants and children and may be associated with loss of chromosome 22.  It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3B74-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-49EF-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Desmoplastic small round cell tumor","valueDescription":"Desmoplastic Small Round Cell Tumor","ValueMeaning":{"publicId":"3179342","version":"1","preferredName":"Desmoplastic Small Round Cell Tumor","longName":"3179342","preferredDefinition":"An aggressive malignant neoplasm of uncertain lineage.  It is characterized by the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Small Round Cell Tumor","conceptCode":"C8300","definition":"An aggressive malignant soft tissue neoplasm of uncertain differentiation.  It is characterized by a recurrent chromosomal translocation t(11;22)(p13;q12) and the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8341-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-49F9-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Extraskeletal Ewing sarcoma","valueDescription":"Extraosseous Ewing Sarcoma","ValueMeaning":{"publicId":"2672909","version":"1","preferredName":"Extraosseous Ewing Sarcoma","longName":"2672909","preferredDefinition":"This is a rare malignant neoplasm of the soft tissue.  It is typically a disease of children and young adults.  It is characterized by t(11:22) (q24: q12) resulting in the expression of EWS/FLI-1 chimeric transcript.  Most commonly occurs in the paravertebral region, chest wall, pelvis and lower extremities.  Treatment includes local excision with consideration for post operative chemotherapy and/or radiotherapy. - 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extraskeletal Ewing Sarcoma","conceptCode":"C7135","definition":"A rare malignant neoplasm of the soft tissues. It is typically a disease of children and young adults. Most commonly occurs in the paravertebral region, chest wall, pelvis and lower extremities. Treatment includes local excision with consideration for post-operative chemotherapy and/or radiotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A708-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A0D-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Extraskeletal myxoid chondrosarcoma","valueDescription":"Extraskeletal Myxoid Chondrosarcoma","ValueMeaning":{"publicId":"3179350","version":"1","preferredName":"Extraskeletal Myxoid Chondrosarcoma","longName":"3179350","preferredDefinition":"A rare malignant soft tissue neoplasm of uncertain lineage characterized by the presence of chondroblast-like cells in a myxoid stroma and a multinodular growth pattern.  The most common sites of involvement are the deep soft tissues of the extremities, particularly the thigh.  It usually presents as an enlarging soft tissue mass.  Patients may have long survivals, but local recurrences and metastases occur in approximately half of the cases.  The most common site of metastasis is the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extraskeletal Myxoid Chondrosarcoma","conceptCode":"C27502","definition":"A rare malignant soft tissue neoplasm of uncertain differentiation, characterized by the presence of chondroblast-like cells in a myxoid stroma and a multinodular growth pattern.  The most common sites of involvement are the deep soft tissues of the extremities, particularly the thigh.  It usually presents as an enlarging soft tissue mass.  Patients may have long survivals, but local recurrences and metastases occur in approximately half of the cases.  The most common site of metastasis is the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8467-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A17-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Clear cell sarcoma of soft tissue","valueDescription":"Clear Cell Sarcoma of Soft Tissue","ValueMeaning":{"publicId":"3179239","version":"1","preferredName":"Clear Cell Sarcoma of Soft Tissue","longName":"3179239","preferredDefinition":"A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Sarcoma of Soft Tissue","conceptCode":"C3745","definition":"A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CE10-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A21-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Alveolar soft-part sarcoma","valueDescription":"Alveolar Soft Part Sarcoma","ValueMeaning":{"publicId":"3179234","version":"1","preferredName":"Alveolar Soft Part Sarcoma","longName":"3179234","preferredDefinition":"A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alveolar Soft Part Sarcoma","conceptCode":"C3750","definition":"A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CD57-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A35-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Epithelioid sarcoma","valueDescription":"Epithelioid Sarcoma","ValueMeaning":{"publicId":"3179347","version":"1","preferredName":"Epithelioid Sarcoma","longName":"3179347","preferredDefinition":"An aggressive malignant neoplasm of uncertain lineage, characterized by the presence of epithelioid cells forming nodular patterns.  The nodules often undergo central necrosis, resulting in a pseudogranulomatous growth pattern.  It usually occurs in young adults.  The most common sites of involvement are the extremities (distal-type epithelioid sarcoma), and less frequently the pelvis, perineum, and genital organs (proximal-type epithelioid sarcoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Sarcoma","conceptCode":"C3714","definition":"An aggressive malignant neoplasm of uncertain differentiation, characterized by the presence of epithelioid cells forming nodular patterns.  The nodules often undergo central necrosis, resulting in a pseudogranulomatous growth pattern.  It usually occurs in young adults.  The most common sites of involvement are the extremities (distal-type epithelioid sarcoma), and less frequently the pelvis, perineum, and genital organs (proximal-type epithelioid sarcoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-83F8-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A3F-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Synovial sarcoma, biphasic","valueDescription":"Biphasic Synovial Sarcoma","ValueMeaning":{"publicId":"3835971","version":"1","preferredName":"Biphasic Synovial Sarcoma","longName":"3835971","preferredDefinition":"A synovial sarcoma characterized by the presence of both an epithelial and a spindle cell component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphasic Synovial Sarcoma","conceptCode":"C4279","definition":"A synovial sarcoma characterized by the presence of both an epithelial and a spindle cell component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2E8B052-3587-E7A7-E040-BB89AD43282F","latestVersionIndicator":"Yes","beginDate":"2013-08-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-08-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A53-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Synovial sarcoma, spindle cell","valueDescription":"Spindle Cell Synovial Sarcoma","ValueMeaning":{"publicId":"4824492","version":"1","preferredName":"Spindle Cell Synovial Sarcoma","longName":"4824492","preferredDefinition":"A synovial sarcoma characterized by the presence of a spindle cell component only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spindle Cell Synovial Sarcoma","conceptCode":"C4277","definition":"A synovial sarcoma characterized by the presence of a spindle cell component only.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4A60-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A79-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Synovial sarcoma NOS","valueDescription":"Synovial sarcoma","ValueMeaning":{"publicId":"2568843","version":"1","preferredName":"Synovial sarcoma","longName":"2568843","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4A8D-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myoepithelial carcinoma","valueDescription":"Malignant Myoepithelioma","ValueMeaning":{"publicId":"3248547","version":"1","preferredName":"Malignant Myoepithelioma","longName":"3248547","preferredDefinition":"An infiltrating malignant epithelial neoplasm characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Myoepithelioma","conceptCode":"C7596","definition":"An infiltrating malignant tumor characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BB70-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4AEA-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myoepithelioma","valueDescription":"Myoepithelial Neoplasm","ValueMeaning":{"publicId":"4824497","version":"1","preferredName":"Myoepithelial Neoplasm","longName":"4824497","preferredDefinition":"A benign or malignant epithelial neoplasm characterized by the presence of cells that show myoepithelial differentiation. Based on its morphologic features, it is classified as benign or malignant. A representative example of benign myoepithelioma is benign salivary gland myoepithelioma. Representative examples of malignant myoepithelioma or myoepithelial carcinoma are malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myoepithelial Tumor","conceptCode":"C40392","definition":"A benign or malignant tumor characterized by the presence of cells that show myoepithelial differentiation. Based on its morphologic features, it is classified as benign or malignant. A representative example of benign myoepithelioma is benign salivary gland myoepithelioma. Representative examples of malignant myoepithelioma or myoepithelial carcinoma are malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4AF7-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4B10-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Ectomesenchymoma","valueDescription":"Sarcoma with Ganglionic or Neuroectodermal Differentiation","ValueMeaning":{"publicId":"3251864","version":"1","preferredName":"Sarcoma with Ganglionic or Neuroectodermal Differentiation","longName":"3251864","preferredDefinition":"An aggressive malignant mesenchymal neoplasm of the nervous system or soft tissues. It is characterized by the presence of a sarcomatous component (most often rhabdomyosarcoma) and a ganglionic or a neuroectodermal component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ectomesenchymoma","conceptCode":"C4716","definition":"An exceedingly rare, aggressive malignant mesenchymal neoplasm characterized by the presence of a sarcomatous component and a ganglionic or a neuroectodermal component.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A771271B-00BA-B6CD-E040-BB89AD436FA1","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4CE9-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignant granular cell tumor","valueDescription":"Malignant Granular Cell Tumor","ValueMeaning":{"publicId":"4824518","version":"1","preferredName":"Malignant Granular Cell Tumor","longName":"4824518","preferredDefinition":"An uncommon granular cell tumor which may metastasize to other anatomic sites. Morphologic characteristics include the presence of spindling neoplastic cells, necrosis, extensive pleomorphism, prominent nucleoli, and increased mitiotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Granular Cell Tumor","conceptCode":"C4336","definition":"An uncommon granular cell tumor which may metastasize to other anatomic sites. Morphologic characteristics include the presence of spindling neoplastic cells, necrosis, extensive pleomorphism, prominent nucleoli, and increased mitiotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4CF6-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4D0F-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignant Triton tumor","valueDescription":"Malignant Triton Tumor","ValueMeaning":{"publicId":"4824520","version":"1","preferredName":"Malignant Triton Tumor","longName":"4824520","preferredDefinition":"A malignant peripheral nerve sheath tumor which shows rhabdomyosarcomatous differentiation. More than half of the patients have neurofibromatosis type 1. The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Triton Tumor","conceptCode":"C4335","definition":"A malignant peripheral nerve sheath tumor which shows rhabdomyosarcomatous differentiation. More than half of the patients have neurofibromatosis type 1. The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4D1C-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4D35-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Epithelioid malignant nerve sheath tumor","valueDescription":"Epithelioid Malignant Peripheral Nerve Sheath Tumor","ValueMeaning":{"publicId":"4824521","version":"1","preferredName":"Epithelioid Malignant Peripheral Nerve Sheath Tumor","longName":"4824521","preferredDefinition":"A rare variant of malignant peripheral nerve sheath tumor composed predominantly or exclusively of epithelioid cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Malignant Peripheral Nerve Sheath Tumor","conceptCode":"C6561","definition":"A rare variant of malignant peripheral nerve sheath tumor composed predominantly or exclusively of epithelioid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4D3F-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4D58-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignant peripheral nerve sheath tumor","valueDescription":"Malignant Peripheral Nerve Sheath Tumor","ValueMeaning":{"publicId":"2838605","version":"1","preferredName":"Malignant Peripheral Nerve Sheath Tumor","longName":"2838605","preferredDefinition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peripheral Nerve Sheath Tumor","conceptCode":"C3798","definition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AE88-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4D62-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Ectopic meningioma","valueDescription":"Ectopic Meningioma","ValueMeaning":{"publicId":"4824526","version":"1","preferredName":"Ectopic Meningioma","longName":"4824526v1.00","preferredDefinition":"A meningothelial neoplasm that arises from an anatomic site outside the intracranial and intraspinal compartments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ectopic Meningioma","conceptCode":"C5308","definition":"A meningothelial neoplasm that arises from an anatomic site outside the intracranial and intraspinal compartments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4DD8-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4DF1-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Granular cell tumor","valueDescription":"Granular Cell Tumor","ValueMeaning":{"publicId":"4824530","version":"1","preferredName":"Granular Cell Tumor","longName":"4824530","preferredDefinition":"An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granular Cell Tumor","conceptCode":"C3474","definition":"An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4E44-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4E5C-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignant perineurioma","valueDescription":"Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation","ValueMeaning":{"publicId":"4824532","version":"1","preferredName":"Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation","longName":"4824532","preferredDefinition":"A malignant peripheral nerve sheath tumor mainly composed of tumor cells showing perineurial cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation","conceptCode":"C66845","definition":"A very rare malignant tumor with morphologic features similar to those of benign perineurioma of soft tissue along with hypercellularity, nuclear atypia, hyperchromasia, and a high mitotic rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4E6A-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4E83-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Perineurioma","valueDescription":"Perineurioma","ValueMeaning":{"publicId":"4824534","version":"1","preferredName":"Perineurioma","longName":"4824534","preferredDefinition":"A rare, benign tumor composed entirely of neoplastic perineurial cells. It may occur intraneurally or in the soft tissues.  (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perineurioma","conceptCode":"C4973","definition":"A rare benign tumor composed entirely of neoplastic perineurial cells. It may occur in the soft tissues, intraneurally or in mucosal sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4E90-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4EA8-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Plexiform neurofibroma","valueDescription":"Plexiform Neurofibroma","ValueMeaning":{"publicId":"2838639","version":"1","preferredName":"Plexiform Neurofibroma","longName":"2838639","preferredDefinition":"An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plexiform Neurofibroma","conceptCode":"C3797","definition":"An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6E019-5A5E-F2F6-E040-BB89AD4350E9","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4EBD-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Neurofibroma (including variants)","valueDescription":"Neurofibroma","ValueMeaning":{"publicId":"2838641","version":"1","preferredName":"Neurofibroma","longName":"2838641","preferredDefinition":"An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths. It is composed of perineurial-like fibroblasts and Schwann cells. It usually presents as a localized cutaneous lesion and less often as a circumscribed peripheral nerve mass. Patients with neurofibromatosis type 1 present with multiple masses. Neurofibromas which arise from major nerves and plexiform neurofibromas are precursor lesions to malignant peripheral nerve sheath tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibroma","conceptCode":"C3272","definition":"An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths. It is composed of perineurial-like fibroblasts and Schwann cells. It usually presents as a localized cutaneous lesion and less often as a circumscribed peripheral nerve mass. Patients with neurofibromatosis type 1 present with multiple masses. Neurofibromas which arise from major nerves and plexiform neurofibromas are precursor lesions to malignant peripheral nerve sheath tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6E019-5A84-F2F6-E040-BB89AD4350E9","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4ED1-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Melanotic schwannoma","valueDescription":"Melanotic Schwannoma","ValueMeaning":{"publicId":"4824535","version":"1","preferredName":"Melanotic Schwannoma","longName":"4824535","preferredDefinition":"A rare, circumscribed, non-encapsulated and grossly pigmented variant of schwannoma.  It is composed of cells with the immunophenotypic and electron microscopic features of Schwann cells which contain melanosomes and are positive for melanoma markers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanotic Schwannoma","conceptCode":"C6970","definition":"A rare circumscribed, non-encapsulated and grossly pigmented nerve sheath tumor. It is composed of cells with the immunophenotypic and electron microscopic features of Schwann cells which contain melanosomes and are positive for melanoma markers. It usually involves spinal nerve roots but may occur in other locations. It may be associated with PRKAR1A gene mutation and Carney complex. Malignant behavior has been reported in a significant number of patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4EDC-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4EF5-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Schwannoma (including variants)","valueDescription":"Schwannoma","ValueMeaning":{"publicId":"2575032","version":"1","preferredName":"Schwannoma","longName":"2575032","preferredDefinition":"A tumor of the peripheral nervous system that arises in the nerve sheath (protective covering).  It is almost always benign, but rare malignant schwannomas have been reported.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schwannoma","conceptCode":"C3269","definition":"A benign, usually encapsulated slow growing tumor composed of Schwann cells.  It affects peripheral and cranial nerves.  It recurs infrequently and only rare cases associated with malignant transformation have been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F225-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-23","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4F09-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Gastrointestinal stromal tumor, malignant","valueDescription":"Malignant Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4824537","version":"1","preferredName":"Malignant Gastrointestinal Stromal Tumor","longName":"4824537","preferredDefinition":"A gastrointestinal stromal tumor that is characterized by large size (diameter greater than 10 cm for gastric localization and greater than 5 cm for intestinal localization) or more than 5 mitotic figures per 50 high power fields.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Gastrointestinal Stromal Tumor","conceptCode":"C53999","definition":"A gastrointestinal stromal tumor that is characterized by large size (diameter greater than 10 cm for gastric localization and greater than 5 cm for intestinal localization) or more than 5 mitotic figures per 50 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4F16-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4F2E-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Gastrointestinal stromal tumor, uncertain malignant potential","valueDescription":"Gastrointestinal Stromal Tumor of Uncertain Malignant Potential","ValueMeaning":{"publicId":"3249587","version":"1","preferredName":"Gastrointestinal Stromal Tumor of Uncertain Malignant Potential","longName":"3249587","preferredDefinition":"A gastrointestinal stromal tumor that is characterized by a maximum diameter greater than 5 cm and equal or less than 10 cm (gastric localization), or greater than 2 cm and equal or less than 5 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor of Uncertain Malignant Potential","conceptCode":"C54000","definition":"A gastrointestinal stromal tumor that is characterized by a maximum diameter greater than 5 cm and equal or less than 10 cm (gastric localization), or greater than 2 cm and equal or less than 5 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D99025-BEEA-DBB4-E040-BB89AD434418","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4F43-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Benign gastrointestinal stromal tumor","valueDescription":"Benign Gastrointestinal Stromal Tumor","ValueMeaning":{"publicId":"4824539","version":"1","preferredName":"Benign Gastrointestinal Stromal Tumor","longName":"4824539","preferredDefinition":"A gastrointestinal stromal tumor that is characterized by a maximum diameter equal or less than 5 cm (gastric localization), or equal or less than 2 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Gastrointestinal Stromal Tumor","conceptCode":"C53998","definition":"A gastrointestinal stromal tumor that is characterized by a maximum diameter equal or less than 5 cm (gastric localization), or equal or less than 2 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4F50-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4F69-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Angiosarcoma of soft tissue","valueDescription":"Angiosarcoma of Soft Tissue","ValueMeaning":{"publicId":"4824541","version":"1","preferredName":"Angiosarcoma of Soft Tissue","longName":"4824541","preferredDefinition":"An angiosarcoma that arises from the soft tissues, usually in the deep muscles of the lower extremities, retroperitoneum, mediastinum, and mesentery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Angiosarcoma","conceptCode":"C121671","definition":"An angiosarcoma that arises from the soft tissues, usually in the deep muscles of the lower extremities, retroperitoneum, mediastinum, and mesentery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4F76-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4F8F-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Kaposi sarcoma","valueDescription":"Kaposi sarcoma","ValueMeaning":{"publicId":"2568842","version":"1","preferredName":"Kaposi sarcoma","longName":"2568842","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"UMLLOADER_COPPAPRD","dateModified":"2009-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4F99-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Composite hemangioendothelioma","valueDescription":"Composite Hemangioendothelioma","ValueMeaning":{"publicId":"3123863","version":"1","preferredName":"Composite Hemangioendothelioma","longName":"3123863","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Composite Hemangioendothelioma","conceptCode":"C45475","definition":"An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3BC0-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4FAD-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Papillary intralymphatic angioendothelioma","valueDescription":"Papillary Intralymphatic Angioendothelioma","ValueMeaning":{"publicId":"3123911","version":"1","preferredName":"Papillary Intralymphatic Angioendothelioma","longName":"3123911","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Intralymphatic Angioendothelioma","conceptCode":"C7526","definition":"An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-43E3-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4FB7-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myofibroma","valueDescription":"Myofibroma","ValueMeaning":{"publicId":"3249533","version":"1","preferredName":"Myofibroma","longName":"3249533","preferredDefinition":"A benign localized neoplasm arising from the subcutaneous tissues and skeletal muscle. It is characterized by the presence of myofibroblastic hyperchromatic spindle cells, hylanized stroma formation, calcification, necrosis, and a multinodular growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myofibroma","conceptCode":"C7052","definition":"A benign, localized, nodular and well-circumscribed neoplasm usually seen as a congenital neoplasm or in the first year of life. It is characterized by a biphasic growth pattern and is composed of small, undifferentiated mesenchymal cells associated with branching thin-walled vessels and more mature neoplastic spindle cells with abundant eosinophilic cytoplasm in a collagenous stroma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-0713-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B2C5-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myopericytoma","valueDescription":"Myopericytoma","ValueMeaning":{"publicId":"4824385","version":"1","preferredName":"Myopericytoma","longName":"4824385","preferredDefinition":"A usually slow growing, subcutaneous nodular neoplasm arising from myopericytes.  It is composed of myoid cells arranged in a perivascular growth pattern.  The vast majority of cases have a benign clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myopericytoma","conceptCode":"C50401","definition":"A usually slow growing, subcutaneous nodular neoplasm arising from myopericytes.  It is composed of myoid cells arranged in a perivascular growth pattern.  The vast majority of cases have a benign clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B2D2-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B2EB-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignant glomus tumor","valueDescription":"Malignant Glomus Tumor","ValueMeaning":{"publicId":"3123921","version":"1","preferredName":"Malignant Glomus Tumor","longName":"3123921","preferredDefinition":"A very rare morphologic variant of glomus tumor with a size greater than 2 cm.  The tumor arises in subfascial or visceral tissues. It characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both.  It has an aggressive clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Glomus Tumor","conceptCode":"C4221","definition":"A very rare morphologic variant of glomus tumor with a size greater than 2 cm.  The tumor arises in subfascial or visceral tissues. It is characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both.  It has an aggressive clinical course.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-44A1-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B2FF-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Glomangiomatosis","valueDescription":"Glomangiomatosis","ValueMeaning":{"publicId":"4824387","version":"1","preferredName":"Glomangiomatosis","longName":"4824387","preferredDefinition":"A benign multifocal proliferation of glomus cells forming clusters around dilated vascular spaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glomangiomatosis","conceptCode":"C27496","definition":"A benign multifocal proliferation of glomus cells forming clusters around dilated vascular spaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B30C-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B325-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Glomus tumor (and variants)","valueDescription":"Glomus Tumor","ValueMeaning":{"publicId":"3211100","version":"1","preferredName":"Glomus Tumor","longName":"3211100","preferredDefinition":"A rare benign or malignant mesenchymal neoplasm arising from cells that resemble the modified smooth muscle cells of the glomus body. The majority of glomus tumors occur in the distal extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glomus Tumor","conceptCode":"C3060","definition":"A rare benign or malignant mesenchymal neoplasm arising from cells that resemble the modified smooth muscle cells of the glomus body. The majority of glomus tumors occur in the distal extremities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-CDD0-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B339-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Leiomyosarcoma (excluding skin)","valueDescription":"Leiomyosarcoma","ValueMeaning":{"publicId":"4824388","version":"1","preferredName":"Leiomyosarcoma","longName":"4824388","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B344-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B35C-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Leiomyoma of deep soft tissue","valueDescription":"Deep Leiomyoma","ValueMeaning":{"publicId":"4824390","version":"1","preferredName":"Deep Leiomyoma","longName":"4824390","preferredDefinition":"A rare benign smooth muscle neoplasm arising from deep tissue. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep Leiomyoma","conceptCode":"C6512","definition":"A rare benign smooth muscle neoplasm arising from deep tissue. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B36A-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B383-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Giant cell tumor of soft tissue","valueDescription":"Giant Cell Tumor of Soft Tissue","ValueMeaning":{"publicId":"4824392","version":"1","preferredName":"Giant Cell Tumor of Soft Tissue","longName":"4824392","preferredDefinition":"A painless, well circumscribed tumor arising in soft tissue, usually of the upper and lower extremities. Morphologically, it is characterized by a multinodular growth pattern. The cellular infiltrate is composed of mononuclear round or oval cells and multinucleated osteoclast-like giant cells, in a rich vascular stroma.  It rarely metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Tumor of Soft Tissue","conceptCode":"C49107","definition":"A painless, well circumscribed tumor arising in soft tissue, usually of the upper and lower extremities. Morphologically, it is characterized by a multinodular growth pattern. The cellular infiltrate is composed of mononuclear round or oval cells and multinucleated osteoclast-like giant cells, in a rich vascular stroma.  It rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B390-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B3A9-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Plexiform fibrohistiocytic tumor","valueDescription":"Plexiform Fibrohistiocytic Tumor","ValueMeaning":{"publicId":"4824394","version":"1","preferredName":"Plexiform Fibrohistiocytic Tumor","longName":"4824394","preferredDefinition":"An intermediate cutaneous fibrohistiocytic neoplasm that usually affects children and young adults.  It is a multinodular, poorly circumscribed tumor characterized by the presence of multinucleated giant cells, mononuclear histiocyte-like cells, and spindle fibroblast-like cells arranged in a plexiform pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plexiform Fibrohistiocytic Tumor","conceptCode":"C6493","definition":"An intermediate fibrohistiocytic neoplasm of the skin that usually affects children and young adults. It is a multinodular, poorly circumscribed tumor characterized by the presence of multinucleated giant cells, mononuclear histiocyte-like cells, and spindle fibroblast-like cells arranged in a plexiform pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B3B6-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B3CF-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Deep benign fibrous histiocytoma","valueDescription":"Deep Benign Fibrous Histiocytoma","ValueMeaning":{"publicId":"4824396","version":"1","preferredName":"Deep Benign Fibrous Histiocytoma","longName":"4824396","preferredDefinition":"A rare, well-circumscribed, pseudo-encapsulated benign fibrous histiocytoma that arises entirely within the subcutaneous tissue or deep soft tissue.  It usually affects the extremities or the head and neck region.  It recurs locally in a minority of cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep Fibrous Histiocytoma","conceptCode":"C6492","definition":"A rare, well-circumscribed, pseudo-encapsulated benign fibrous histiocytoma that arises entirely within the subcutaneous tissue or deep soft tissue.  It usually affects the extremities or the head and neck region.  It recurs locally in a minority of cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B3DC-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B3F5-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Malignant tenosynovial giant cell tumor","valueDescription":"Malignant Giant Cell Tumor of Tendon Sheath","ValueMeaning":{"publicId":"3179359","version":"1","preferredName":"Malignant Giant Cell Tumor of Tendon Sheath","longName":"3179359","preferredDefinition":"An uncommon malignant tumor arising from the tendon sheath. Morphologically, it is characterized by the presence of a cellular infiltrate reminiscent of a giant cell tumor with prominent malignant characteristics. Recurrent giant cell tumors with a sarcomatous dedifferentiation are included in this category as well.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Tenosynovial Giant Cell Tumor","conceptCode":"C6535","definition":"An uncommon malignant tumor arising from the tendon sheath. Morphologically, it is characterized by the presence of a cellular infiltrate reminiscent of a giant cell tumor with prominent malignant characteristics. Recurrent giant cell tumors with a sarcomatous dedifferentiation are included in this category as well.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-85B0-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B409-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Tenosynovial giant cell tumor diffuse type","valueDescription":"Tenosynovial Giant Cell Tumor, Diffuse Type","ValueMeaning":{"publicId":"4824398","version":"1","preferredName":"Tenosynovial Giant Cell Tumor, Diffuse Type","longName":"4824398","preferredDefinition":"A locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath.  It is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells.  Multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare.  It predominantly affects young adults.  Symptoms include joint swelling, pain, and joint effusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tenosynovial Giant Cell Tumor, Diffuse Type","conceptCode":"C3401","definition":"A locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath.  It is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells.  Multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare.  It predominantly affects young adults.  Symptoms include joint swelling, pain, and joint effusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B416-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B42F-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Tenosynovial giant cell tumor localized type","valueDescription":"Localized Giant Cell Tumor of Tendon Sheath","ValueMeaning":{"publicId":"3249736","version":"1","preferredName":"Localized Giant Cell Tumor of Tendon Sheath","longName":"3249736","preferredDefinition":"A well-circumscribed, lobulated tumor, completely or partially covered by a fibrous capsule. It usually arises in the fingers.  It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. The tumor is slow-growing, usually developing over several years. Clinical presentation includes painless edema of the affected site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tenosynovial Giant Cell Tumor, Localized Type","conceptCode":"C6532","definition":"A well-circumscribed, lobulated tumor, completely or partially covered by a fibrous capsule. It usually arises in the fingers.  It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. The tumor is slow-growing, usually developing over several years. Clinical presentation includes painless edema of the affected site.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-391A-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B443-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Tenosynovial giant cell tumor","valueDescription":"Giant Cell Tumor of Tendon Sheath","ValueMeaning":{"publicId":"4824400","version":"1","preferredName":"Giant Cell Tumor of Tendon Sheath","longName":"4824400","preferredDefinition":"A tumor usually arising in the synovium of joints, bursa or tendon sheath. It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. According to the growth pattern, it is classified as localized or diffuse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tenosynovial Giant Cell Tumor","conceptCode":"C3402","definition":"A tumor usually arising in the synovium of joints, bursa or tendon sheath. It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. According to the growth pattern, it is classified as localized or diffuse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B450-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B469-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Sclerosing epithelioid fibrosarcoma","valueDescription":"Sclerosing Epithelioid Fibrosarcoma","ValueMeaning":{"publicId":"3123904","version":"1","preferredName":"Sclerosing Epithelioid Fibrosarcoma","longName":"3123904","preferredDefinition":"A well-circumscribed rare morphologic variant of fibrosarcoma, that arises from the soft tissues. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sclerosing Epithelioid Fibrosarcoma","conceptCode":"C49027","definition":"A well-circumscribed malignant fibroblastic neoplasm that usually arises from the soft tissue. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4336-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B473-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Low-grade fibromyxoid sarcoma","valueDescription":"Low Grade Fibromyxoid Sarcoma","ValueMeaning":{"publicId":"4824401","version":"1","preferredName":"Low Grade Fibromyxoid Sarcoma","longName":"4824401","preferredDefinition":"A low grade, late-metastasizing variant of fibrosarcoma characterized by alternating fibrous and myxoid areas and a whorling growth pattern.  The neoplastic cells have a spindle morphology, and lack hyperchromasia or significant nuclear atypia.  Approximately 40% of cases show the focal presence of collagen rosettes.  A t(7;16)(q33;p11) translocation has been identified in the majority of cases, associated with the presence of FUS-CREB3L2 fusion protein.  Rare cases carry the t(11;16)(p11;p11) translocation which is associated with the presence of the FUS-CREB3L1 fusion protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Fibromyxoid Sarcoma","conceptCode":"C45202","definition":"A low-grade, late-metastasizing variant of fibrosarcoma characterized by alternating fibrous and myxoid areas and a whorling growth pattern.  The neoplastic cells have a spindle morphology, and lack hyperchromasia or significant nuclear atypia.  Approximately 40% of cases show the focal presence of collagen rosettes.  A t(7;16)(q33;p11) translocation has been identified in the majority of cases, associated with the presence of FUS-CREB3L2 fusion protein.  Rare cases carry the t(11;16)(p11;p11) translocation which is associated with the presence of the FUS-CREB3L1 fusion protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B47D-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B495-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myxofibrosarcoma","valueDescription":"Myxofibrosarcoma","ValueMeaning":{"publicId":"4824402","version":"1","preferredName":"Myxofibrosarcoma","longName":"4824402","preferredDefinition":"A spectrum of malignant fibroblastic neoplasms arising from the soft tissues. It is characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxofibrosarcoma","conceptCode":"C6496","definition":"A malignant fibroblastic neoplasm arising from the soft tissue. It is characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B4A0-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B4B8-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Adult fibrosarcoma","valueDescription":"Adult Fibrosarcoma","ValueMeaning":{"publicId":"4824404","version":"1","preferredName":"Adult Fibrosarcoma","longName":"4824404","preferredDefinition":"A malignant mesenchymal tumor composed of fibroblasts, and characterized by collagen production and a herringbone architectural pattern.  It is more commonly seen in middle-aged and older adults.  It usually affects the deep soft tissues of extremities, trunk, head and neck.  Adult fibrosarcomas may recur and metastasise to the lungs and bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult Fibrosarcoma","conceptCode":"C7809","definition":"A malignant mesenchymal neoplasm composed of fibroblasts.  It is characterized by collagen production and a herringbone architectural pattern.  It is more commonly seen in middle-aged and older adults.  It usually affects the deep soft tissues of extremities, trunk, head and neck.  Adult fibrosarcomas may recur and metastasize to the lungs and bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B4C6-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B4DF-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Infantile fibrosarcoma","valueDescription":"Infantile Fibrosarcoma","ValueMeaning":{"publicId":"4824405","version":"1","preferredName":"Infantile Fibrosarcoma","longName":"4824405","preferredDefinition":"A fibrosarcoma that occurs in infants.  It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion.  It usually affects the superficial and deep soft tissues of the extremities.  The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infantile Fibrosarcoma","conceptCode":"C4244","definition":"A fibrosarcoma that occurs in infants.  It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion.  It usually affects the superficial and deep soft tissues of the extremities.  The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B4E9-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B501-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myxoinflammatory fibroblastic sarcoma / Atypical myxoinflammatory fibroblastic tumor","valueDescription":"Myxoinflammatory Fibroblastic Sarcoma","ValueMeaning":{"publicId":"3123915","version":"1","preferredName":"Myxoinflammatory Fibroblastic Sarcoma","longName":"3123915","preferredDefinition":"A low grade multinodular malignant neoplasm arising from the soft tissues.  It is characterized by the presence of spindle-shaped fibroblasts, multivacuolated lipoblast-like cells, bizarre ganglion-like cells with inclusion-like nuclei, myxoid stroma formation, and a mixture of acute and chronic inflammatory infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoinflammatory Fibroblastic Sarcoma","conceptCode":"C49025","definition":"A low grade, locally aggressive, fibroblastic neoplasm that occurs primarily in the distal extremities.  It is characterized by the presence of spindle-shaped fibroblasts, multivacuolated lipoblast-like cells, bizarre ganglion-like cells with inclusion-like nuclei, myxoid stroma formation, and a mixture of acute and chronic inflammatory cells.  Distant metastases are very rare.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-442F-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B516-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Low grade myofibroblastic sarcoma","valueDescription":"Low Grade Myofibroblastic Sarcoma","ValueMeaning":{"publicId":"4824406","version":"1","preferredName":"Low Grade Myofibroblastic Sarcoma","longName":"4824406","preferredDefinition":"A low grade malignant neoplasm arising from the deep soft tissues.  It is characterized by the presence of spindle-shaped myofibroblasts and collagenous stroma formation in a storiform growth pattern.  Metastasis is very rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Myofibroblastic Sarcoma","conceptCode":"C49024","definition":"A low-grade malignant neoplasm arising from the soft tissue and rarely bone. It is characterized by the presence of spindle-shaped myofibroblasts and collagenous stroma formation in a storiform growth pattern. Metastasis is very rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B520-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B538-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Inflammatory myofibroblastic tumor","valueDescription":"Inflammatory Myofibroblastic Tumor","ValueMeaning":{"publicId":"3249211","version":"1","preferredName":"Inflammatory Myofibroblastic Tumor","longName":"3249211","preferredDefinition":"A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Myofibroblastic Tumor","conceptCode":"C6481","definition":"A multinodular intermediate fibroblastic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1BF3-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B54D-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Solitary fibrous tumor, malignant","valueDescription":"Malignant Solitary Fibrous Tumor","ValueMeaning":{"publicId":"3123919","version":"1","preferredName":"Malignant Solitary Fibrous Tumor","longName":"3123919","preferredDefinition":"A malignant neoplasm of probable fibroblastic derivation. It is characterized by the presence of atypical round to spindle-shaped cells, increased cellularity, necrotic change and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Solitary Fibrous Tumor","conceptCode":"C6894","definition":"A malignant neoplasm of probable fibroblastic derivation. It is characterized by the presence of atypical round to spindle-shaped cells, increased cellularity, necrotic change and high mitotic activity.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-447B-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B561-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Pigmented dermatofibrosarcoma protuberans","valueDescription":"Pigmented Dermatofibrosarcoma Protuberans","ValueMeaning":{"publicId":"4824408","version":"1","preferredName":"Pigmented Dermatofibrosarcoma Protuberans","longName":"4824408","preferredDefinition":"A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of melanin-pigmented dendritic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pigmented Dermatofibrosarcoma Protuberans","conceptCode":"C9430","definition":"A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of melanin-pigmented dendritic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B582-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B59B-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Fibrosarcomatous dermatofibrosarcoma protuberans","valueDescription":"Fibrosarcomatous Dermatofibrosarcoma Protuberans","ValueMeaning":{"publicId":"4824410","version":"1","preferredName":"Fibrosarcomatous Dermatofibrosarcoma Protuberans","longName":"4824410","preferredDefinition":"A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of a fibrosarcomatous component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosarcomatous Dermatofibrosarcoma Protuberans","conceptCode":"C27547","definition":"A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of a fibrosarcomatous component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B5A8-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B5C1-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Dermatofibrosarcoma protuberans","valueDescription":"Dermatofibrosarcoma Protuberans","ValueMeaning":{"publicId":"4824411","version":"1","preferredName":"Dermatofibrosarcoma Protuberans","longName":"4824411","preferredDefinition":"A low grade fibroblastic neoplasm presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities.  The tumor diffusely infiltrates the dermis and the subcutaneous tissues.  It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatofibrosarcoma Protuberans","conceptCode":"C4683","definition":"A low grade fibroblastic neoplasm presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities.  The tumor diffusely infiltrates the dermis and the subcutaneous tissues.  It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B5CB-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B5E3-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Giant cell fibroblastoma","valueDescription":"Giant Cell Fibroblastoma","ValueMeaning":{"publicId":"3249226","version":"1","preferredName":"Giant Cell Fibroblastoma","longName":"3249226","preferredDefinition":"An intermediate cutaneous fibrohistiocytic neoplasm typically affecting young patients (predominantly boys), characterized by painless nodules in the dermis or subcutaneous tissues. Morphologically, it contains giant cells and wide vessel-like spaces.  This tumor can recur, but metastases have not been reported.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Fibroblastoma","conceptCode":"C4700","definition":"A rare, locally aggressive fibroblastic neoplasm typically affecting young patients (predominantly boys).  It manifests with painless nodules in the dermis or subcutaneous tissues. Morphologically, it contains giant cells and wide vessel-like spaces.  This tumor can recur but metastases have not been reported.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1D39-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B5F8-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Lipofibromatosis","valueDescription":"Lipofibromatosis","ValueMeaning":{"publicId":"4824413","version":"1","preferredName":"Lipofibromatosis","longName":"4824413","preferredDefinition":"A rare, slow-growing, painless tumor of infancy and early childhood that usually affects the distal extremities. It is characterized by the presence of alternating bands of mature adipose tissue and spindle-cell fibrous tissue, without destruction of the adipose tissue architecture. It does not metastasize, however the rate of local recurrences is high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipofibromatosis","conceptCode":"C99180","definition":"A rare, slow-growing, painless tumor of infancy and early childhood that usually affects the distal extremities. It is characterized by the presence of alternating bands of mature adipose tissue and spindle-cell fibrous tissue, without destruction of the adipose tissue architecture. It does not metastasize, however the rate of local recurrences is high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B605-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B61E-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Desmoid-type fibromatosis","valueDescription":"Deep Fibromatosis/Desmoid Tumor","ValueMeaning":{"publicId":"3249213","version":"1","preferredName":"Deep Fibromatosis/Desmoid Tumor","longName":"3249213","preferredDefinition":"An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoid Fibromatosis","conceptCode":"C9182","definition":"An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1C19-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B632-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Plantar fibromatosis","valueDescription":"Plantar Fibromatosis","ValueMeaning":{"publicId":"3249545","version":"1","preferredName":"Plantar Fibromatosis","longName":"3249545","preferredDefinition":"A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plantar Fibromatosis","conceptCode":"C4680","definition":"A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-084B-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B646-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Palmar fibromatosis","valueDescription":"Palmar Fibromatosis","ValueMeaning":{"publicId":"3211333","version":"1","preferredName":"Palmar Fibromatosis","longName":"3211333","preferredDefinition":"A superficial fibromatosis arising from the soft tissue of the palm. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It predominantly affects adult males.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palmar Fibromatosis","conceptCode":"C3469","definition":"A superficial fibromatosis arising from the soft tissue of the palm. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It predominantly affects adult males.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EF41-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B65A-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Calcifying fibrous tumor","valueDescription":"Calcifying Fibrous Tumor","ValueMeaning":{"publicId":"4824415","version":"1","preferredName":"Calcifying Fibrous Tumor","longName":"4824415","preferredDefinition":"A benign well-circumscribed paucicellular lesion arising from the soft tissues. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, psammoma bodies, and dystrophic calcifications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calcifying Fibrous Tumor","conceptCode":"C6488","definition":"A benign well-circumscribed lesion arising from the soft tissues. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, psammoma bodies, and dystrophic calcifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B667-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B680-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Gardner fibroma","valueDescription":"Gardner Fibroma","ValueMeaning":{"publicId":"4824417","version":"1","preferredName":"Gardner Fibroma","longName":"4824417","preferredDefinition":"An uncommon, poorly circumscribed, benign neoplasm arising in the soft tissues of infants, children and adolescents. It is characterized by the presence of haphazardly arranged spindle-shaped fibroblasts, collagenous stroma formation, and plaque-like growth pattern. There is a strong genetic component associating the neoplasm with Gardners syndrome and deep fibromatosis/desmoid tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gardner Fibroma","conceptCode":"C49017","definition":"An uncommon, poorly circumscribed, benign neoplasm arising in the soft tissues of infants, children and adolescents. It is characterized by the presence of haphazardly arranged spindle-shaped fibroblasts, collagenous stroma formation, and plaque-like growth pattern. There is a strong genetic component associating the neoplasm with Gardners syndrome and deep fibromatosis/desmoid tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B68D-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B6A6-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Nuchal-type fibroma","valueDescription":"Nuchal-Type Fibroma","ValueMeaning":{"publicId":"4824419","version":"1","preferredName":"Nuchal-Type Fibroma","longName":"4824419","preferredDefinition":"A rare non-encapsulated and poorly circumscribed lesion that usually affects the posterior neck.  It is seen more frequently in men and is characterized by the presence of thick collagen fibers.  It may recur but does not metastasize.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuchal-Type Fibroma","conceptCode":"C6486","definition":"A rare non-encapsulated and poorly circumscribed tumor that usually arises from the posterior neck. It is seen more frequently in men and is characterized by the presence of thick collagen fibers. It may recur but does not metastasize.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B6B3-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B6CC-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Cellular angiofibroma","valueDescription":"Cellular Angiofibroma","ValueMeaning":{"publicId":"4824421","version":"1","preferredName":"Cellular Angiofibroma","longName":"4824421","preferredDefinition":"A benign mesenchymal neoplasm that usually arises in the superficial soft tissues of the vulva or inguinal and scrotal regions.  It is characterized by the presence of a cellular fibroblastic proliferation in an edematous to fibrous stroma containing numerous vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Angiofibroma","conceptCode":"C27257","definition":"A benign mesenchymal neoplasm that usually arises in the superficial soft tissues of the vulva or inguinal and scrotal regions.  It is characterized by the presence of a cellular fibroblastic proliferation in an edematous to fibrous stroma containing numerous vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B6D9-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B6F2-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Angiomyofibroblastoma","valueDescription":"Angiomyofibroblastoma","ValueMeaning":{"publicId":"4824423","version":"1","preferredName":"Angiomyofibroblastoma","longName":"4824423","preferredDefinition":"A benign myofibroblastic neoplasm, usually arising in the pelviperineal region.  It is characterized by the presence of neoplastic spindle to round cells, dilated thin walled vessels, and stromal edema.  Most patients present with painless circumscribed masses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiomyofibroblastoma","conceptCode":"C49016","definition":"A benign myofibroblastic neoplasm, usually arising in the pelviperineal region. It is characterized by the presence of neoplastic spindle to round cells, dilated thin walled vessels, and stromal edema.  Most patients present with painless circumscribed masses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B6FF-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B718-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Calcifying aponeurotic fibroma","valueDescription":"Calcifying Aponeurotic Fibroma","ValueMeaning":{"publicId":"4824425","version":"1","preferredName":"Calcifying Aponeurotic Fibroma","longName":"4824425","preferredDefinition":"A rare slow-growing benign neoplasm arising from the soft tissues in children. It is a poorly circumscribed tumor characterized by the presence of chondrocyte-like cells, nodular calcification, nuclear palisading, and in some cases osteoclastic giant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calcifying Aponeurotic Fibroma","conceptCode":"C4818","definition":"A rare slow-growing benign neoplasm arising from the soft tissues in children. It is a poorly circumscribed tumor characterized by the presence of chondrocyte-like cells, nodular calcification, nuclear palisading, and in some cases osteoclastic giant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B725-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B73E-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Mammary-type myofibroblastoma","valueDescription":"Mammary-Type Myofibroblastoma","ValueMeaning":{"publicId":"4824427","version":"1","preferredName":"Mammary-Type Myofibroblastoma","longName":"4824427","preferredDefinition":"A benign mesenchymal neoplasm characterized by the presence of spindle shaped myofibroblasts and mast cells in a collagenous stroma.  It is histologically identical to the myofibroblastoma of breast.  It usually arises from the subcutaneous tissue and the most common sites of involvement are the inguinal/groin, paratesticular, and vulvovaginal areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mammary-Type Myofibroblastoma","conceptCode":"C121181","definition":"A benign mesenchymal neoplasm characterized by the presence of spindle shaped myofibroblasts and mast cells in a collagenous stroma.  It is histologically identical to the myofibroblastoma of breast.  It usually arises from the subcutaneous tissue and the most common sites of involvement are the inguinal/groin, paratesticular, and vulvovaginal areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B74B-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B764-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Retiform hemangioendothelioma","valueDescription":"Retiform Hemangioendothelioma","ValueMeaning":{"publicId":"3123906","version":"1","preferredName":"Retiform Hemangioendothelioma","longName":"3123906","preferredDefinition":"An intermediate, locally aggressive blood vessel neoplasm.  It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retiform Hemangioendothelioma","conceptCode":"C27511","definition":"An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4371-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4FC1-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Kaposiform hemangioendothelioma","valueDescription":"Kaposiform Hemangioendothelioma","ValueMeaning":{"publicId":"3123926","version":"1","preferredName":"Kaposiform Hemangioendothelioma","longName":"3123926","preferredDefinition":"An intermediate, locally aggressive blood vessel neoplasm characterized by the presence of spindle endothelial cells, and formation of capillary-sized and slit-like vascular channels.  It is often associated with hemorrhage and hemosiderin deposition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposiform Hemangioendothelioma","conceptCode":"C27510","definition":"An intermediate, locally aggressive blood vessel neoplasm characterized by the presence of spindle endothelial cells, and formation of capillary-sized and slit-like vascular channels.  It is often associated with hemorrhage and hemosiderin deposition.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4512-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4FD5-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Solitary fibrous tumor","valueDescription":"Solitary Fibrous Tumor","ValueMeaning":{"publicId":"3249525","version":"1","preferredName":"Solitary Fibrous Tumor","longName":"3249525","preferredDefinition":"A localized neoplasm of probable fibroblastic derivation. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solitary Fibrous Tumor","conceptCode":"C7634","definition":"A localized neoplasm of probable fibroblastic derivation. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-0652-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-4FE9-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Deep \"aggressive\" angiomyxoma","valueDescription":"Deep \"Aggressive\" Angiomyxoma","ValueMeaning":{"publicId":"4824511","version":"1","preferredName":"Deep \"Aggressive\" Angiomyxoma","longName":"4824511","preferredDefinition":"A locally infiltrating, non-metastasizing angiomyxoma arising from the pelviperineal region.  It may recur following resection","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep (Aggressive) Angiomyxoma","conceptCode":"C6936","definition":"A locally infiltrating, non-metastasizing angiomyxoma arising from the pelviperineal region.  It may recur following resection","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4C4D-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-5041-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Epithelioid hemangioma","valueDescription":"Epithelioid Hemangioendothelioma","ValueMeaning":{"publicId":"3179346","version":"1","preferredName":"Epithelioid Hemangioendothelioma","longName":"3179346","preferredDefinition":"A low grade malignant blood vessel neoplasm characterized by the presence of epithelioid endothelial cells, hylanized and myxoid stroma formation, and angiocentricity. It may present as a painful mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Hemangioendothelioma","conceptCode":"C3800","definition":"A low-grade malignant blood vessel neoplasm.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-83D3-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-5055-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Hemangioma","valueDescription":"Hemangioma","ValueMeaning":{"publicId":"4824378","version":"1","preferredName":"Hemangioma","longName":"4824378","preferredDefinition":"A benign vascular lesion characterized by the formation of capillary-sized or cavernous vascular channels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemangioma","conceptCode":"C3085","definition":"A benign vascular lesion characterized by the formation of capillary-sized or cavernous vascular channels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B1D7-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EE070C-5069-0882-E050-BB89AD43797F","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Desmoplastic fibroblastoma","valueDescription":"Desmoplastic Fibroblastoma","ValueMeaning":{"publicId":"4824429","version":"1","preferredName":"Desmoplastic Fibroblastoma","longName":"4824429","preferredDefinition":"A rare benign soft tissue neoplasm characterized by the presence of an abundant collagenous or myxocollagenous matrix, spindle-shaped, and stellate-shaped fibroblasts.  It usually presents as an asymptomatic, slowly growing subcutaneous mass. The most common sites of involvement are the upper arm, shoulder, and lower limb.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Fibroblastoma","conceptCode":"C27515","definition":"A rare benign soft tissue neoplasm characterized by the presence of an abundant collagenous or myxocollagenous matrix, spindle-shaped, and stellate-shaped fibroblasts.  It usually presents as an asymptomatic, slowly growing subcutaneous mass. The most common sites of involvement are the upper arm, shoulder, and lower limb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B771-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B78A-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Fibroma of tendon sheath","valueDescription":"Tendon Sheath Fibroma","ValueMeaning":{"publicId":"3249523","version":"1","preferredName":"Tendon Sheath Fibroma","longName":"3249523","preferredDefinition":"A small, slow growing, benign neoplasm arising from the tendon sheaths. The tumor is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tendon Sheath Fibroma","conceptCode":"C6485","definition":"A small, slow growing, benign neoplasm arising from the tendon sheaths. The tumor is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-062C-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B79E-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Inclusion body fibromatosis","valueDescription":"Inclusion Body Fibromatosis","ValueMeaning":{"publicId":"4824431","version":"1","preferredName":"Inclusion Body Fibromatosis","longName":"4824431","preferredDefinition":"A rare benign neoplasm arising from the soft tissues of the digits, in young children. It is characterized by the presence of fibroblastic spindle cells, and intracytoplasmic eosinophilic spherical inclusions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Body Fibromatosis","conceptCode":"C3456","definition":"A rare benign neoplasm arising from the soft tissues of the digits, in young children. It is characterized by the presence of fibroblastic spindle cells, and intracytoplasmic eosinophilic spherical inclusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B7AB-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B7C4-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Juvenile hyaline fibromatosis","valueDescription":"Juvenile Hyaline Fibromatosis","ValueMeaning":{"publicId":"4824433","version":"1","preferredName":"Juvenile Hyaline Fibromatosis","longName":"4824433","preferredDefinition":"A non-neoplastic connective and soft tissue disorder that usually affects infants. It is characterized by the deposition of extracellular hyaline material in the skin, soft tissues and bones. This results in the development of tumor-like masses. Surgical excision is the treatment of choice, however, local recurrences are common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juvenile Hyaline Fibromatosis","conceptCode":"C98297","definition":"A non-neoplastic connective and soft tissue disorder that usually affects infants. It is characterized by the deposition of extracellular hyaline material in the skin, soft tissues and bones. This results in the development of tumor-like masses. Surgical excision is the treatment of choice, however, local recurrences are common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B7D1-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B7EA-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Fibromatosis colli","valueDescription":"Fibromatosis Colli","ValueMeaning":{"publicId":"4824435","version":"1","preferredName":"Fibromatosis Colli","longName":"4824435","preferredDefinition":"A congenital benign lesion that occurs in the distal sternocleidomastoid muscle of infants. It is characterized by the presence of plump spindle cells, and collagenous stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibromatosis Colli","conceptCode":"C4811","definition":"A congenital benign lesion that occurs in the distal sternocleidomastoid muscle of infants. It is characterized by the presence of plump spindle cells, and collagenous stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B7F7-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B810-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Fibrous hamartoma of infancy","valueDescription":"Fibrous Hamartoma of Infancy","ValueMeaning":{"publicId":"4824437","version":"1","preferredName":"Fibrous Hamartoma of Infancy","longName":"4824437","preferredDefinition":"A poorly circumscribed neoplasm arising from the soft tissues in infants. It is characterized by the presence of bland fibroblastic spindle cells, collagenous stroma formation, primitive mesenchymal round cells, and mature fat cells. These components combined form a distinct organoid pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrous Hamartoma of Infancy","conceptCode":"C3942","definition":"A poorly circumscribed neoplasm arising from the soft tissues in infants. It is characterized by the presence of bland fibroblastic spindle cells, collagenous stroma formation, primitive mesenchymal round cells, and mature fat cells. These components combined form a distinct organoid pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B81D-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B836-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Elastofibroma","valueDescription":"Elastofibroma","ValueMeaning":{"publicId":"3249537","version":"1","preferredName":"Elastofibroma","longName":"3249537","preferredDefinition":"A benign, slow-growing tumor arising from the soft tissues usually in the mid-thoracic region of the elderly. It is characterized by the presence of paucicellular collagenous tissue, adipocytes and a predominance of large coarse elastic fibers arranged in globules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elastofibroma","conceptCode":"C4245","definition":"A benign, slow-growing tumor arising from the soft tissues usually in the mid-thoracic region of the elderly. It is characterized by the presence of paucicellular collagenous tissue, adipocytes and a predominance of large coarse elastic fibers arranged in globules.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-077F-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B84A-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Ischemic fasciitis","valueDescription":"Ischemic Fasciitis","ValueMeaning":{"publicId":"4824439","version":"1","preferredName":"Ischemic Fasciitis","longName":"4824439","preferredDefinition":"A reactive, painless lesion which is characterized by a pseudosarcomatous proliferation of fibroblasts and myofibroblasts usually in the deep subcutaneous tissue. It occurs mainly around the limb girdles, sacral region, and greater trochanter.  It affects mainly elderly patients and sometimes is associated with physical immobility. Local excision is usually curative.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ischemic Fasciitis","conceptCode":"C6483","definition":"A reactive, painless lesion which is characterized by a pseudosarcomatous proliferation of fibroblasts and myofibroblasts usually in the deep subcutaneous tissue. It occurs mainly around the limb girdles, sacral region, and greater trochanter.  It affects mainly elderly patients and sometimes is associated with physical immobility. Local excision is usually curative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B857-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B870-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Fibroosseous pseudotumor of the digits","valueDescription":"Fibroosseous Pseudotumor of the Digits","ValueMeaning":{"publicId":"4824441","version":"1","preferredName":"Fibroosseous Pseudotumor of the Digits","longName":"4824441","preferredDefinition":"A non-neoplastic soft tissue disorder characterized by the localized formation of reactive fibrous and bone tissues.  It usually occurs in the subcutaneous tissue of the proximal phalanx.  Less frequently, it involves the toe.  It presents with swelling and pain of the affected area.  The prognosis is excellent.  However, incomplete excision may lead to the re-growth of the lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibroosseous Pseudotumor of Digits","conceptCode":"C6573","definition":"A self-limited benign neoplasm composed of spindle cells and osteoblasts. It usually occurs in the subcutaneous tissue of the proximal phalanx. Less frequently, it involves the toe. It presents with swelling and pain of the affected area. The prognosis is excellent. However, incomplete excision may lead to the re-growth of the lesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B87D-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B896-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Myositis ossifficans","valueDescription":"Myositis Ossificans","ValueMeaning":{"publicId":"3211278","version":"1","preferredName":"Myositis Ossificans","longName":"3211278","preferredDefinition":"A disorder characterized by non-neoplastic bone formation in soft tissues. It usually follows blunt trauma and bleeding in the deep soft tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myositis Ossificans","conceptCode":"C3253","definition":"A self-limited benign neoplasm characterized by a zonal architecture. It is composed of spindle cells oriented randomly or in short intersecting fascicles. Peripherally, the spindle cells merge with osteoblasts that rim and populate ill-defined trabeculae and sheets of unmineralized woven bone, which is surrounded by well-formed trabecular and cortical-type bone that remodels into lamellar bone. Treatment is usually simple excision. Prognosis is excellent; recurrence is uncommon. (WHO 2020)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E769-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B8AA-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Proliferative myositis","valueDescription":"Proliferative Myositis","ValueMeaning":{"publicId":"4824443","version":"1","preferredName":"Proliferative Myositis","longName":"4824443","preferredDefinition":"A rapidly growing, poorly circumscribed, mass-forming proliferation that arises from the skeletal muscle. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity. It recurs only rarely following local excision and does not metastasize.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferative Myositis","conceptCode":"C121154","definition":"A rapidly growing, poorly circumscribed, mass-forming proliferation that arises from the skeletal muscle. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity. It recurs only rarely following local excision and does not metastasize.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B8B7-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B8D0-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Proliferative fasciitis","valueDescription":"Proliferative Fasciitis","ValueMeaning":{"publicId":"3249527","version":"1","preferredName":"Proliferative Fasciitis","longName":"3249527","preferredDefinition":"A rapid growing, poorly circumscribed, non-encapsulated, benign neoplasm that arises from the subcutaneous tissues. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferative Fasciitis","conceptCode":"C4728","definition":"A rapidly growing, poorly circumscribed, mass-forming proliferation that arises from the subcutaneous tissues. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity. It recurs only rarely following local excision and does not metastasize.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-068C-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B8E4-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Nodular fasciitis","valueDescription":"Nodular Fasciitis","ValueMeaning":{"publicId":"3249529","version":"1","preferredName":"Nodular Fasciitis","longName":"3249529","preferredDefinition":"A rapid growing, non-encapsulated benign neoplasm that arises from the soft tissues. It is characterized by the presence of non-hyperchromatic spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity, in a storiform growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nodular Fasciitis","conceptCode":"C3827","definition":"A self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the soft tissues. It is characterized by the presence of plump spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-06B2-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B8F8-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Liposarcoma, not otherwise specified","valueDescription":"Liposarcoma","ValueMeaning":{"publicId":"2579805","version":"1","preferredName":"Liposarcoma","longName":"2579805","preferredDefinition":"A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Representative morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid/round cell liposarcoma.  The metastatic potential is higher in less differentiated tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liposarcoma","conceptCode":"C3194","definition":"A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid liposarcoma.  The metastatic potential is higher in less differentiated tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04CA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B90C-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"},{"value":"Pleomorphic liposarcoma","valueDescription":"Pleomorphic Liposarcoma","ValueMeaning":{"publicId":"4824444","version":"1","preferredName":"Pleomorphic Liposarcoma","longName":"4824444","preferredDefinition":"A liposarcoma characterized by the presence of varying proportions of pleomorphic lipoblasts in a background that resembles undifferentiated pleomorphic sarcoma.  It is the rarest liposarcoma variant and usually has an aggressive clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Liposarcoma","conceptCode":"C3705","definition":"A rare, aggressive liposarcoma characterized by the presence of varying proportions of pleomorphic lipoblasts in a background that resembles undifferentiated pleomorphic sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B916-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"15EBDE73-B92E-8DA9-E050-BB89AD4368FB","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4824031","version":"1","preferredName":"Sarcoma World Health Organization Classification Category","preferredDefinition":"A usually aggressive malignant neoplasm of soft tissue or bone.  It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.:A United Nations agency established to coordinate international health activities and to help governments improve health services.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C9118:C75419:C25161:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"World Health Organization","conceptCode":"C75419","definition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15E87403-A647-CD32-E050-BB89AD430E3D","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"ONEDATA","dateModified":"2015-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"WHO Classification of Tumours of Soft Tissue and Bone. 2013.  Fourth Edition","workflowStatus":"RELEASED","registrationStatus":"Application","id":"15E87403-A658-CD32-E050-BB89AD430E3D","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":"Sarcoma_DCI_05.12.15_ghd","administrativeNotes":"2023.9.5 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic type:","type":"Preferred Question Text","description":"Histologic type:","url":null,"context":"DCI"}],"origin":"WHO:World Health Organization","workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE371D-3449-2E29-E050-BB89AD430406","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"HARTLEYG","dateModified":"2015-05-15","changeDescription":"Sarcoma_DCI_05.12.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}